<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38911850</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>1363572</StartPage><MedlinePgn>1363572</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1363572</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1363572</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the respiratory distress condition known as COVID-19. This disease broadly affects several physiological systems, including the gastrointestinal, renal, and central nervous (CNS) systems, significantly influencing the patient's overall quality of life. Additionally, numerous risk factors have been suggested, including gender, body weight, age, metabolic status, renal health, preexisting cardiomyopathies, and inflammatory conditions. Despite advances in understanding the genome and pathophysiological ramifications of COVID-19, its precise origins remain elusive. SARS-CoV-2 interacts with a receptor-binding domain within angiotensin-converting enzyme 2 (ACE2). This receptor is expressed in various organs of different species, including humans, with different abundance. Although COVID-19 has multiorgan manifestations, the main pathologies occur in the lung, including pulmonary fibrosis, respiratory failure, pulmonary embolism, and secondary bacterial pneumonia. In the post-COVID-19 period, different sequelae may occur, which may have various causes, including the direct action of the virus, alteration of the immune response, and metabolic alterations during infection, among others. Recognizing the serious adverse health effects associated with COVID-19, it becomes imperative to comprehensively elucidate and discuss the existing evidence surrounding this viral infection, including those related to the pathophysiological effects of the disease and the subsequent consequences. This review aims to contribute to a comprehensive understanding of the impact of COVID-19 and its long-term effects on human health.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Carvajal, Garc&#xed;a-Castillo, Cuellar, Campillay-V&#xe9;liz, Salazar-Ardiles, Avellaneda, Mu&#xf1;oz, Retamal-D&#xed;az, Bueno, Gonz&#xe1;lez, Kalergis and Lay.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Carvajal</LastName><ForeName>Jonatan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Garc&#xed;a-Castillo</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuellar</LastName><ForeName>Shelsy V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campillay-V&#xe9;liz</LastName><ForeName>Claudia P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Biological Sciences, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salazar-Ardiles</LastName><ForeName>Camila</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Research in Physiology and Altitude Medicine (FIMEDALT), Biomedical Department, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avellaneda</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Sciences, Faculty of Sciences, Universidad Santo Tom&#xe1;s, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Research Center in Immunology and Biomedical Biotechnology of Antofagasta (CIIBBA), University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Technology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, Department of Medical Technology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Retamal-D&#xed;az</LastName><ForeName>Angello</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center in Immunology and Biomedical Biotechnology of Antofagasta (CIIBBA), University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, Department of Medical Technology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bueno</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Pablo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalergis</LastName><ForeName>Alexis M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Endocrinolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lay</LastName><ForeName>Margarita K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center in Immunology and Biomedical Biotechnology of Antofagasta (CIIBBA), University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Department of Biotechnology, Faculty of Marine Sciences and Biological Resources, Department of Medical Technology, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">host factors</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">variants</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38911850</ArticleId><ArticleId IdType="pmc">PMC11190347</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1363572</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497&#x2013;506. doi:&#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727&#x2013;33. doi:&#xa0;10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. . Severe acute respiratory syndrome-related coronavirus: The species and its viruses&#x2013;a statement of the Coronavirus Study Group. BioRxiv. (2020). doi:&#xa0;10.1101/2020.02.07.937862</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.07.937862</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, et al. . Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. (2020) 20:e238&#x2013;44. doi:&#xa0;10.1016/S1473-3099(20)30484-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30484-9</ArticleId><ArticleId IdType="pmc">PMC7333991</ArticleId><ArticleId IdType="pubmed">32628905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-coV-2 and COVID-19. Nat Rev Microbiol. (2021) 19:141&#x2013;54. doi:&#xa0;10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis. (2021) 1:5. doi:&#xa0;10.1186/s44149-021-00005-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s44149-021-00005-9</ArticleId><ArticleId IdType="pmc">PMC8062217</ArticleId><ArticleId IdType="pubmed">34778878</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Ho W, Huang Y, Jin D-Y, Li S, Liu S-L, et al. . SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. (2020) 395:949&#x2013;50. doi:&#xa0;10.1016/S0140-6736(20)30557-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30557-2</ArticleId><ArticleId IdType="pmc">PMC7133598</ArticleId><ArticleId IdType="pubmed">32151324</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik YA. Properties of coronavirus and SARS-coV-2. Malaysian J Pathol. (2020) 42:3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32342926</ArticleId></ArticleIdList></Reference><Reference><Citation>Flerlage T, Boyd DF, Meliopoulos V, Thomas PG, Schultz-Cherry S. Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract. Nat Rev Microbiol. (2021) 19:425&#x2013;41. doi:&#xa0;10.1038/s41579-021-00542-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00542-7</ArticleId><ArticleId IdType="pmc">PMC8023351</ArticleId><ArticleId IdType="pubmed">33824495</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman Z, Li M, Wang X. Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses. Front Immunol. (2020) 11:552909. doi:&#xa0;10.3389/fimmu.2020.552909</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.552909</ArticleId><ArticleId IdType="pmc">PMC7516028</ArticleId><ArticleId IdType="pubmed">33013925</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E, Ackerley J, Aelmans M, Ali N, Ashcroft Z, Ashton C, et al. . Structural bases of zoonotic and zooanthroponotic transmission of SARS-CoV-2. Viruses. (2022) 14. doi:&#xa0;10.3390/v14020418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020418</ArticleId><ArticleId IdType="pmc">PMC8875863</ArticleId><ArticleId IdType="pubmed">35216011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395:565&#x2013;74. doi:&#xa0;10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenuto D, Angeletti S, Giovanetti M, Bianchi M, Pascarella S, Cauda R, et al. . Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy. J Infect. (2020) 81:e24&#x2013;7. doi:&#xa0;10.1016/j.jinf.2020.03.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.058</ArticleId><ArticleId IdType="pmc">PMC7195303</ArticleId><ArticleId IdType="pubmed">32283146</ArticleId></ArticleIdList></Reference><Reference><Citation>Frutos R, Pliez O, Gavotte L, Devaux CA. There is no &#x201c;origin&#x201d; to SARS-CoV-2. Environ Res. (2022) 207:112173. doi:&#xa0;10.1016/j.envres.2021.112173</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2021.112173</ArticleId><ArticleId IdType="pmc">PMC8493644</ArticleId><ArticleId IdType="pubmed">34626592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, et al. . Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. (2020) 583:282&#x2013;5. doi:&#xa0;10.1038/s41586-020-2169-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2169-0</ArticleId><ArticleId IdType="pubmed">32218527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo WK, de Oliveira&#x2010;Filho EF, Rasche A, Greenwood AD, Osterrieder K, Drexler JF. Potential zoonotic sources of SARS-CoV-2 infections. Transboundary emerging Dis. (2021) 68:1824&#x2013;34. doi:&#xa0;10.1111/tbed.13872</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.13872</ArticleId><ArticleId IdType="pmc">PMC7675418</ArticleId><ArticleId IdType="pubmed">33034151</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. . Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. (2002) 417:822&#x2013;8. doi:&#xa0;10.1038/nature00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Peron JPS, Nakaya H. Susceptibility of the elderly to SARS-CoV-2 infection: ACE-2 overexpression, shedding, and antibody-dependent enhancement (ADE). Clinics. (2020) 75:e1912. doi:&#xa0;10.6061/clinics/2020/e1912</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2020/e1912</ArticleId><ArticleId IdType="pmc">PMC7213670</ArticleId><ArticleId IdType="pubmed">32428113</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu LP, Zhang XL, Li J. New perspectives on angiotensin-converting enzyme 2&#xa0;and its related diseases. World J Diabetes. (2021) 12:839&#x2013;54. doi:&#xa0;10.4239/wjd.v12.i6.839</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v12.i6.839</ArticleId><ArticleId IdType="pmc">PMC8192247</ArticleId><ArticleId IdType="pubmed">34168732</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Gandica J, Winter D, Schnippe R, Rodriguez-Morales AG, Mondragon J, Escalera-Antezana JP, et al. . Ageusia and anosmia, a common sign of COVID-19? A case series from four countries. J Neurovirol. (2020) 26:785&#x2013;9. doi:&#xa0;10.1007/s13365-020-00875-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00875-8</ArticleId><ArticleId IdType="pmc">PMC7359421</ArticleId><ArticleId IdType="pubmed">32666422</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta RAH, Garrigos ZE, Marcelin JR, Vijayvargiya P. COVID-19 pathogenesis and clinical manifestations. Infect Dis Clinics. (2022) 36:231&#x2013;49. doi:&#xa0;10.1016/j.idc.2022.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8806149</ArticleId><ArticleId IdType="pubmed">35636898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadirvelu B, Burcea G, Quint JK, Costelloe CE, Faisal AA. Covid-19 does not look like what you are looking for: clustering symptoms by nation and multi-morbidities reveal substantial differences to the classical symptom triad. medRxiv. (2021). doi:&#xa0;10.1101/2021.04.02.21254818</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.02.21254818</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. . Early transmission dynamics in Wuhan, China, of novel coronavirus&#x2013;infected pneumonia. New Engl J Med. (2020) 382:1199&#x2013;207. doi:&#xa0;10.1056/NEJMoa2001316</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao W, Gladstone P, Engardt S, Greenbaum C, Palmer JP. Major histocompatibility complex class I molecule expression is normal on peripheral blood lymphocytes from patients with insulin-dependent diabetes mellitus. J Clin Invest. (1996) 98:1613&#x2013;8. doi:&#xa0;10.1172/JCI118955</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118955</ArticleId><ArticleId IdType="pmc">PMC507594</ArticleId><ArticleId IdType="pubmed">8833910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Li TK, Lee CH, Chow ES, Lee ACH, Tam AR, et al. . A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19. Diabetes Res Clin Pract. (2022) 185:109232. doi:&#xa0;10.1016/j.diabres.2022.109232</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.109232</ArticleId><ArticleId IdType="pmc">PMC8816793</ArticleId><ArticleId IdType="pubmed">35131374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampasona V, Secchi M, Scavini M, Bazzigaluppi E, Brigatti C, Marzinotto I, et al. . Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. (2020) 63:2548&#x2013;58. doi:&#xa0;10.1007/s00125-020-05284-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-020-05284-4</ArticleId><ArticleId IdType="pmc">PMC7541098</ArticleId><ArticleId IdType="pubmed">33029657</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. (2020) 41:1141&#x2013;9. doi:&#xa0;10.1038/s41401-020-0485-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0485-4</ArticleId><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. (2021) 53:1623&#x2013;9. doi:&#xa0;10.1007/s11255-020-02740-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-020-02740-3</ArticleId><ArticleId IdType="pmc">PMC7778685</ArticleId><ArticleId IdType="pubmed">33389508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Karuppanan K, Subramaniam G. Omicron (BA. 1) and sub-variants (BA. 1.1, BA. 2, and BA. 3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment. J Med Virol. (2022) 94(10):4780&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9347785</ArticleId><ArticleId IdType="pubmed">35680610</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson N, Nelveg-Kristensen KE, Ballegaard Freese E, Feldt-Rasmussen B, Hornum M, Kamper AL, et al. . Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med. (2021) 290:166&#x2013;78. doi:&#xa0;10.1111/joim.13239</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13239</ArticleId><ArticleId IdType="pmc">PMC8014284</ArticleId><ArticleId IdType="pubmed">33452733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rincon-Arevalo H, Choi M, Stefanski AL, Halleck F, Weber U, Szelinski F, et al. . Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol. (2021) 6:eabj1031. doi:&#xa0;10.1126/sciimmunol.abj1031</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abj1031</ArticleId><ArticleId IdType="pubmed">34131023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, et al. . The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant. Transplantation. (2022) 106:821&#x2013;34. doi:&#xa0;10.1097/TP.0000000000003983</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003983</ArticleId><ArticleId IdType="pmc">PMC8942603</ArticleId><ArticleId IdType="pubmed">34753894</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. (2021) 21:855. doi:&#xa0;10.1186/s12879-021-06536-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. (2020) 8:475&#x2013;81. doi:&#xa0;10.1016/S2213-2600(20)30079-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. . Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. (2020) 41:1821&#x2013;9. doi:&#xa0;10.1093/eurheartj/ehaa600</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa600</ArticleId><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I, et al. . Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. (2022) 603:706&#x2013;14. doi:&#xa0;10.1038/s41586-022-04474-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04474-x</ArticleId><ArticleId IdType="pmc">PMC8942856</ArticleId><ArticleId IdType="pubmed">35104837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndrome: Clin Res Rev. (2020) 14:247&#x2013;50. doi:&#xa0;10.1016/j.dsx.2020.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7102662</ArticleId><ArticleId IdType="pubmed">32247212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau JJ, et al. . Real-world COVID-19 vaccine effectiveness against the Omicron&#xa0;BA. 2 variant in a SARS-CoV-2 infection-naive population. Nat Med. (2023) 29(2):348&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9941049</ArticleId><ArticleId IdType="pubmed">36652990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H, et al. . Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa. Nat Med. (2022) 28(9):1785&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499863</ArticleId><ArticleId IdType="pubmed">35760080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatucci M, et al. . Omicron variant evolution on vaccines and monoclonal antibodies. Inflammopharmacology. (2023) 31(4):1779&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10198014</ArticleId><ArticleId IdType="pubmed">37204696</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. . Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5. Nature. (2022) 608(7923):603&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385487</ArticleId><ArticleId IdType="pubmed">35790190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, et al. . BA. 2.12. 1, BA. 4 and BA. 5 escape antibodies elicited by Omicron infection. Nature. (2022) 608(7923):593&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385493</ArticleId><ArticleId IdType="pubmed">35714668</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G, et al. . Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. (2020) 9:1417. doi:&#xa0;10.3390/jcm9051417</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051417</ArticleId><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. (2020) 17:543&#x2013;58. doi:&#xa0;10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. . Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. (2020) 5:279&#x2013;84. doi:&#xa0;10.1136/svn-2020-000431</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, et al. . Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology. Am J Prev Cardiol. (2020) 1:100009. doi:&#xa0;10.1016/j.ajpc.2020.100009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpc.2020.100009</ArticleId><ArticleId IdType="pmc">PMC7194073</ArticleId><ArticleId IdType="pubmed">32835347</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto ICDP, Barreto BAP, Cavalcante EGN, Neto AC. Immunological deficiencies: more frequent than they seem to be. Jornal Pediatria. (2021) 97:49&#x2013;58. doi:&#xa0;10.1016/j.jped.2020.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2020.10.009</ArticleId><ArticleId IdType="pmc">PMC9432333</ArticleId><ArticleId IdType="pubmed">33238140</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryadevara N, Shrihari S, Gilchuk P, VanBlargan LA, Binshtein E, Zost SJ, et al. . Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. (2021) 184:2316&#x2013;2331.e15. doi:&#xa0;10.1016/j.cell.2021.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC7962591</ArticleId><ArticleId IdType="pubmed">33773105</ArticleId></ArticleIdList></Reference><Reference><Citation>Milota T, Sobotkova M, Smetanova J, Bloomfield M, Vydlakova J, Chovancova Z, et al. . Risk factors for severe COVID-19 and hospital admission in patients with inborn errors of immunity-results from a multicenter nationwide study. Front Immunol. (2022) 13:835770. doi:&#xa0;10.3389/fimmu.2022.835770</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.835770</ArticleId><ArticleId IdType="pmc">PMC8918471</ArticleId><ArticleId IdType="pubmed">35296097</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ, et al. . COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect. (2021) 82:329&#x2013;38. doi:&#xa0;10.1016/j.jinf.2021.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.022</ArticleId><ArticleId IdType="pmc">PMC7859698</ArticleId><ArticleId IdType="pubmed">33549624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitiku H, Weldegebreal F, Teklemariam Z. Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia. In: HIV/AIDS-Research and Palliative Care (2015). p. 137&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4435443</ArticleId><ArticleId IdType="pubmed">25999763</ArticleId></ArticleIdList></Reference><Reference><Citation>Chepkondol GK, Jolly PE, Yatich N, Mbowe O, Jaoko WG. Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya. Afr Health Sci. (2020) 20:615&#x2013;24. doi:&#xa0;10.4314/ahs.v20i2.9</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v20i2.9</ArticleId><ArticleId IdType="pmc">PMC7609085</ArticleId><ArticleId IdType="pubmed">33163022</ArticleId></ArticleIdList></Reference><Reference><Citation>Groban L, Wang H, Sun X, Ahmad S, Ferrario CM. Is sex a determinant of COVID-19 infection? Truth myth? Curr Hypertension Rep. (2020) 22:1&#x2013;12. doi:&#xa0;10.1007/s11906-020-01073-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-020-01073-x</ArticleId><ArticleId IdType="pmc">PMC7449867</ArticleId><ArticleId IdType="pubmed">32852624</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg G, Rybakova D, Fischer D, Cernava T, Verges MC, Charles T, et al. . Microbiome definition re-visited: old concepts and new challenges. Microbiome. (2020) 8:1&#x2013;22. doi:&#xa0;10.1186/s40168-020-00875-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-00875-0</ArticleId><ArticleId IdType="pmc">PMC7329523</ArticleId><ArticleId IdType="pubmed">32605663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousa WK, Chehadeh F, Husband S. Recent advances in understanding the structure and function of the human microbiome. Front Microbiol. (2022) 13:825338. doi:&#xa0;10.3389/fmicb.2022.825338</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.825338</ArticleId><ArticleId IdType="pmc">PMC8851206</ArticleId><ArticleId IdType="pubmed">35185849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Price J, Mahurkar A, Rahnavard G, Crabtree J, Orvis J, Hall AB, et al. . Strains, functions and dynamics in the expanded Human Microbiome Project. Nature. (2017) 550:61&#x2013;6. doi:&#xa0;10.1038/nature23889</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23889</ArticleId><ArticleId IdType="pmc">PMC5831082</ArticleId><ArticleId IdType="pubmed">28953883</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Oxford University Press US; (2020) p. 420&#x2013;1.</Citation></Reference><Reference><Citation>Moore SC, Penrice-Randal R, Alruwaili M, Dong X, Pullan ST, Carter DP, et al. . Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19. MedRxiv. (2020). doi:&#xa0;10.1101/2020.03.05.20032011</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.05.20032011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. . Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. (2020) 159:944&#x2013;955 e8. doi:&#xa0;10.1053/j.gastro.2020.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventero MP, Cuadrat RRC, Vidal I, Andrade BGN, Molina-Pardines C, Haro-Moreno JM, et al. . Nasopharyngeal microbial communities of patients infected with SARS-CoV-2 that developed COVID-19. Front Microbiol. (2021) 12:637430. doi:&#xa0;10.3389/fmicb.2021.637430</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.637430</ArticleId><ArticleId IdType="pmc">PMC8010661</ArticleId><ArticleId IdType="pubmed">33815323</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman RJ. Distinct systemic and mucosal immune responses during acute SARS-coV-2 infection. Israel Med Assoc J. (2021), 751&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553615</ArticleId><ArticleId IdType="pubmed">34471264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilts MH, Rosas-Salazar C, Strickland BA, Kimura KS, Asad M, Sehanobish E, et al. . Severe COVID-19 is associated with an altered upper respiratory tract microbiome. Front Cell infection Microbiol. (2022) 11:781968. doi:&#xa0;10.3389/fcimb.2021.781968</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.781968</ArticleId><ArticleId IdType="pmc">PMC8819187</ArticleId><ArticleId IdType="pubmed">35141167</ArticleId></ArticleIdList></Reference><Reference><Citation>Danwang C, Endomba FT, Nkeck JR, Wouna DLA, Robert A, Noubiap JJ, et al. . A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). biomark Res. (2020) 8:1&#x2013;13. doi:&#xa0;10.1186/s40364-020-00217-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-020-00217-0</ArticleId><ArticleId IdType="pmc">PMC7456766</ArticleId><ArticleId IdType="pubmed">32879731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D, Pandit R, Sharma S, Raval J, Patel Z, Joshi M, et al. . Nasopharyngeal microbiome of COVID-19 patients revealed a distinct bacterial profile in deceased and recovered individuals. Microb Pathog. (2022) 173:105829. doi:&#xa0;10.1016/j.micpath.2022.105829</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105829</ArticleId><ArticleId IdType="pmc">PMC9568276</ArticleId><ArticleId IdType="pubmed">36252893</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;lhave M, Agergaard J, Wejse C. Clinical management of COVID-19 patients&#x2013;an update. In: Seminars in nuclear medicine. Elsevier; (2022) 2(1):4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206588</ArticleId><ArticleId IdType="pubmed">34243904</ArticleId></ArticleIdList></Reference><Reference><Citation>Daria S, Islam MR. The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue. J Med Virol. (2022) 94:2343. doi:&#xa0;10.1002/jmv.27635</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27635</ArticleId><ArticleId IdType="pmc">PMC9015536</ArticleId><ArticleId IdType="pubmed">35098543</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmarajan T, Paudel KJ, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, et al. . Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Environ Sci pollut Res. (2022) 29:54072&#x2013;87. doi:&#xa0;10.1007/s11356-022-20984-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-022-20984-7</ArticleId><ArticleId IdType="pmc">PMC9163295</ArticleId><ArticleId IdType="pubmed">35657545</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. (2022) 399:2263&#x2013;4. doi:&#xa0;10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Vihta KD, Pouwels KB, Peto TE, Pritchard E, House T, Studley R, et al. . Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clin Infect Dis. (2022) 76:e133&#x2013;41. doi:&#xa0;10.1101/2022.01.18.22269082</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.18.22269082</ArticleId><ArticleId IdType="pmc">PMC9384604</ArticleId><ArticleId IdType="pubmed">35917440</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. doi:&#xa0;10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. (2022) 23:194&#x2013;202. doi:&#xa0;10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Zorita S, Milton-Laskibar I, Garc&#xed;a-Arellano L, Gonz&#xe1;lez M, Portillo MP, et al. . An overview of adipose tissue ACE2 modulation by diet and obesity. Potential implications in COVID-19 infection and severity. Int J Mol Sci. (2021) 22:7975. doi:&#xa0;10.3390/ijms22157975</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157975</ArticleId><ArticleId IdType="pmc">PMC8347022</ArticleId><ArticleId IdType="pubmed">34360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J immunopathology Pharmacol. (2021) 35:20587384211048026. doi:&#xa0;10.1177/20587384211048026</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20587384211048026</ArticleId><ArticleId IdType="pmc">PMC8477699</ArticleId><ArticleId IdType="pubmed">34569339</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya KP, Ghimire TR, Subramanya SH. Access to and equitable distribution of COVID-19 vaccine in low-income countries. NPJ Vaccines. (2021) 6:54. doi:&#xa0;10.1038/s41541-021-00323-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-021-00323-6</ArticleId><ArticleId IdType="pmc">PMC8047027</ArticleId><ArticleId IdType="pubmed">33854072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KV. Problems associated with antiviral drugs and vaccines development for COVID-19: approach to intervention using expression vectors via GPI anchor. Nucleosides Nucleotides Nucleic Acids. (2021) 40:665&#x2013;706. doi:&#xa0;10.1080/15257770.2021.1914851</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15257770.2021.1914851</ArticleId><ArticleId IdType="pmc">PMC8127170</ArticleId><ArticleId IdType="pubmed">33982646</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips N. The coronavirus is here to stay&#x2013;here&#x2019;s what that means. Nature. (2021) 590:382&#x2013;5. doi:&#xa0;10.1038/d41586-021-00396-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00396-2</ArticleId><ArticleId IdType="pubmed">33594289</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel CJ, Mayer C, Poch, Thompson JD. Characterization of accessory genes in coronavirus genomes. Virology J. (2020) 17:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450977</ArticleId><ArticleId IdType="pubmed">32854725</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. . Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. (2020) 27(3):325&#x2013;8. doi:&#xa0;10.1016/j.chom.2020.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.02.001</ArticleId><ArticleId IdType="pmc">PMC7154514</ArticleId><ArticleId IdType="pubmed">32035028</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y-Z, Wang S-Y, Zheng Z-Q, Huang Y, Li W-W, Xu Z-S, et al. . SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response. Cell Mol Immunol. (2021) 18:613&#x2013;20. doi:&#xa0;10.1038/s41423-020-00571-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00571-x</ArticleId><ArticleId IdType="pmc">PMC7588591</ArticleId><ArticleId IdType="pubmed">33110251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu J, Xu J, Zhang L, Shu T, Wu D, Huang M, et al. . SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells. Sci China Life Sci. (2020) 63:1413&#x2013;6. doi:&#xa0;10.1007/s11427-020-1692-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1692-1</ArticleId><ArticleId IdType="pmc">PMC7154568</ArticleId><ArticleId IdType="pubmed">32291557</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SJ, Shin OS. SARS-CoV-2 nucleocapsid protein targets RIG-I-like receptor pathways to inhibit the induction of interferon response. Cells. (2021) 10:530. doi:&#xa0;10.3390/cells10030530</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030530</ArticleId><ArticleId IdType="pmc">PMC7999926</ArticleId><ArticleId IdType="pubmed">33801464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Deng J, Han L, Zhuang M-W, Xu Y, Zhang J, et al. . SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Signal transduction targeted Ther. (2022) 7:22. doi:&#xa0;10.1038/s41392-022-00878-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00878-3</ArticleId><ArticleId IdType="pmc">PMC8785035</ArticleId><ArticleId IdType="pubmed">35075101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell TJ, John S. Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas. Immunology. (2005) 114:301&#x2013;12. doi:&#xa0;10.1111/j.1365-2567.2005.02091.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2005.02091.x</ArticleId><ArticleId IdType="pmc">PMC1782085</ArticleId><ArticleId IdType="pubmed">15720432</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Ye Q, Singh D, Cao Y, Diedrich JK, Yates JR, III, et al. . The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat Commun. (2021) 12:502. doi:&#xa0;10.1038/s41467-020-20768-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20768-y</ArticleId><ArticleId IdType="pmc">PMC7820290</ArticleId><ArticleId IdType="pubmed">33479198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat EA, Sajjad N, Ali A, Aldakheel FM, Mateen A, Alqahtani MS, et al. . SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis&#x2013;an updated review. Int Immunopharmacol. (2021) 95:107493. doi:&#xa0;10.1016/j.intimp.2021.107493</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107493</ArticleId><ArticleId IdType="pmc">PMC7904465</ArticleId><ArticleId IdType="pubmed">33721758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Lv P, Li M, Chen Z, Xin H, Reilly S, et al. . SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomedicine Pharmacotherapy. (2023) 159:114242. doi:&#xa0;10.1016/j.biopha.2023.114242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114242</ArticleId><ArticleId IdType="pmc">PMC9832061</ArticleId><ArticleId IdType="pubmed">36652729</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepley-McTaggart A, Sagum CA, Oliva I, Rybakovsky E, DiGuilio K, Liang J, et al. . SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1. PloS One. (2021) 16:e0251955. doi:&#xa0;10.1371/journal.pone.0251955</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251955</ArticleId><ArticleId IdType="pmc">PMC8189464</ArticleId><ArticleId IdType="pubmed">34106957</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler L-A, et al. . SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. (2020) 27:959&#x2013;66. doi:&#xa0;10.1038/s41594-020-0511-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0511-8</ArticleId><ArticleId IdType="pubmed">32908316</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Ishida R, Strilets T, Cole J, Lopez-Orozco J, Fayad N, et al. . SARS-CoV-2 nonstructural protein 1 inhibits the interferon response by causing depletion of key host signaling factors. J Virol. (2021) 95. doi:&#xa0;10.1128/jvi.00266-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00266-21</ArticleId><ArticleId IdType="pmc">PMC8316110</ArticleId><ArticleId IdType="pubmed">34110264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N-E, Kim D-K, Song Y-J. SARS-CoV-2 nonstructural proteins 1 and 13 suppress caspase-1 and the NLRP3 inflammasome activation. Microorganisms. (2021) 9:494. doi:&#xa0;10.3390/microorganisms9030494</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9030494</ArticleId><ArticleId IdType="pmc">PMC7996899</ArticleId><ArticleId IdType="pubmed">33652815</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. . Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. (2020) 11:3810. doi:&#xa0;10.1038/s41467-020-17665-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. (2020) 92:584&#x2013;8. doi:&#xa0;10.1002/jmv.25719</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25719</ArticleId><ArticleId IdType="pmc">PMC7228367</ArticleId><ArticleId IdType="pubmed">32083328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Chen Y, Wu W, Chen Z. Structure and function of N-terminal zinc finger domain of SARS-CoV-2 NSP2. Virologica Sin. (2021) 36:1104&#x2013;12. doi:&#xa0;10.1007/s12250-021-00431-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-021-00431-6</ArticleId><ArticleId IdType="pmc">PMC8365134</ArticleId><ArticleId IdType="pubmed">34398430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Azumaya CM, Moritz M, Pourmal S, Diallo A, Merz GE, et al. . CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes. Res square. (2021). doi:&#xa0;10.21203/rs.3.rs-515215/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-515215/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasuga Y, Zhu B, Jang K-J, Yoo J-S. Innate immune sensing of coronavirus and viral evasion strategies. Exp Mol Med. (2021) 53:723&#x2013;36. doi:&#xa0;10.1038/s12276-021-00602-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00602-1</ArticleId><ArticleId IdType="pmc">PMC8099713</ArticleId><ArticleId IdType="pubmed">33953325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Ma&#x2010;Lauer Y, Han Y, Thoms M, Buschauer R, Jores J, et al. . The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation. EMBO J. (2021) 40:e102277. doi:&#xa0;10.15252/embj.2019102277</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102277</ArticleId><ArticleId IdType="pmc">PMC8167360</ArticleId><ArticleId IdType="pubmed">33876849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavigne M, Helynck O, Rigolet P, Boudria-Souilah R, Nowakowski M, Baron B, et al. . SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction. Nucleic Acids Res. (2021) 49:7695&#x2013;712. doi:&#xa0;10.1093/nar/gkab571</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab571</ArticleId><ArticleId IdType="pmc">PMC8287907</ArticleId><ArticleId IdType="pubmed">34232992</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Du W, Sang X, Tong Q, Wang Y, Chen G, et al. . RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection. Nat Commun. (2022) 13:1444. doi:&#xa0;10.1038/s41467-022-29135-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29135-5</ArticleId><ArticleId IdType="pmc">PMC8931161</ArticleId><ArticleId IdType="pubmed">35301316</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, Limpens RW, Zevenhoven-Dobbe JC, Laugks U, Zheng S, de Jong AW, et al. . A molecular pore spans the double membrane of the coronavirus replication organelle. Science. (2020) 369:1395&#x2013;8. doi:&#xa0;10.1126/science.abd3629</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3629</ArticleId><ArticleId IdType="pmc">PMC7665310</ArticleId><ArticleId IdType="pubmed">32763915</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Lee J-H, Parker ZM, Acharya D, Chiang JJ, van Gent M, et al. . ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity. Nat Microbiol. (2021) 6:467&#x2013;78. doi:&#xa0;10.1038/s41564-021-00884-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00884-1</ArticleId><ArticleId IdType="pmc">PMC8103894</ArticleId><ArticleId IdType="pubmed">33727702</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, et al. . Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. (2020) 587:657&#x2013;62. doi:&#xa0;10.1038/s41586-020-2601-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2601-5</ArticleId><ArticleId IdType="pmc">PMC7116779</ArticleId><ArticleId IdType="pubmed">32726803</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo LC, Tomasin R, Matos IA, Manucci AC, Sowa ST, Dale K, et al. . The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling. J Biol Chem. (2021) 297. doi:&#xa0;10.1101/2021.04.06.438552</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.06.438552</ArticleId><ArticleId IdType="pmc">PMC8332738</ArticleId><ArticleId IdType="pubmed">34358560</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackstadt T, Chiramel AI, Hoyt FH, Williamson BN, Dooley CA, Beare PA, et al. . Disruption of the Golgi apparatus and contribution of the endoplasmic reticulum to the SARS-CoV-2 replication complex. Viruses. (2021) 13:1798. doi:&#xa0;10.3390/v13091798</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091798</ArticleId><ArticleId IdType="pmc">PMC8473243</ArticleId><ArticleId IdType="pubmed">34578379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai Y, Kawachi K, Terada Y, Omori H, Matsuura Y, Kamitani W. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. Virology. (2017) 510:165&#x2013;74. doi:&#xa0;10.1016/j.virol.2017.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.07.019</ArticleId><ArticleId IdType="pmc">PMC7111695</ArticleId><ArticleId IdType="pubmed">28738245</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Li Z, Guo J, Xu S, Zhou J, Chen Q, et al. . SARS-CoV-2 nsp5 exhibits stronger catalytic activity and interferon antagonism than its SARS-CoV ortholog. J Virol. (2022) 96:e00037&#x2013;22. doi:&#xa0;10.1128/jvi.00037-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00037-22</ArticleId><ArticleId IdType="pmc">PMC9044939</ArticleId><ArticleId IdType="pubmed">35389264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J-L, Zhou X-L. SARS-CoV-2 main protease Nsp5 cleaves and inactivates human tRNA methyltransferase TRMT1. J Mol Cell Biol. (2023) 15:mjad024. doi:&#xa0;10.1093/jmcb/mjad024</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjad024</ArticleId><ArticleId IdType="pmc">PMC10399916</ArticleId><ArticleId IdType="pubmed">37073102</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S-Y, Siu K-L, Lin H, Yeung ML, Jin D-Y. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. Int J Biol Sci. (2021) 17:1547. doi:&#xa0;10.7150/ijbs.59943</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59943</ArticleId><ArticleId IdType="pmc">PMC8071772</ArticleId><ArticleId IdType="pubmed">33907518</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Su J, Shen S, Hu Y, Huang D, Zheng W, et al. . Unique and complementary suppression of cGAS-STING and RNA sensing-triggered innate immune responses by SARS-CoV-2 proteins. Signal transduction targeted Ther. (2021) 6:123. doi:&#xa0;10.1038/s41392-021-00515-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00515-5</ArticleId><ArticleId IdType="pmc">PMC7958565</ArticleId><ArticleId IdType="pubmed">33723219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Ma L, Zhuang Z, Cai S, Zhao Z, Zhou L, et al. . Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal transduction targeted Ther. (2020) 5:221. doi:&#xa0;10.1038/s41392-020-00332-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00332-2</ArticleId><ArticleId IdType="pmc">PMC7537955</ArticleId><ArticleId IdType="pubmed">33024073</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqil M, Ollivier E, Chiu H.-P, Tol Van S, Rudolffi-Soto P, Stevens C, et al. . SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Emerging Microbes infections. (2021) 10:178&#x2013;95. doi:&#xa0;10.1080/22221751.2020.1870414</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1870414</ArticleId><ArticleId IdType="pmc">PMC7850364</ArticleId><ArticleId IdType="pubmed">33372854</ArticleId></ArticleIdList></Reference><Reference><Citation>Vela JM. Repurposing sigma-1 receptor ligands for COVID-19 therapy? Front Pharmacol. (2020) 11:582310. doi:&#xa0;10.3389/fphar.2020.582310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.582310</ArticleId><ArticleId IdType="pmc">PMC7751758</ArticleId><ArticleId IdType="pubmed">33364957</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, Zhang X, Chen JY-C, Wang H, et al. . Evasion of type I interferon by SARS-CoV-2. Cell Rep. (2020) 33. doi:&#xa0;10.1016/j.celrep.2020.108234</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Liu Y, Huang Z, Xu W, Hu W, Yi L, et al. . SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1. Cell Death Differentiation. (2022) 29:1240&#x2013;54. doi:&#xa0;10.1038/s41418-021-00916-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00916-7</ArticleId><ArticleId IdType="pmc">PMC9177730</ArticleId><ArticleId IdType="pubmed">34997207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Guo S, Yi D, Li Q, Ma L, Zhang Y, et al. . A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. Antiviral Res. (2021) 190:105078. doi:&#xa0;10.1016/j.antiviral.2021.105078</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2021.105078</ArticleId><ArticleId IdType="pmc">PMC8059291</ArticleId><ArticleId IdType="pubmed">33894278</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Shi P-Y. Antagonism of type I interferon by severe acute respiratory syndrome coronavirus 2. J Interferon Cytokine Res. (2020) 40:543&#x2013;8. doi:&#xa0;10.1089/jir.2020.0214</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2020.0214</ArticleId><ArticleId IdType="pmc">PMC7757701</ArticleId><ArticleId IdType="pubmed">33337934</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi RK, Koganti R, Agelidis A, Patil CD, Shukla D. Dysregulation of cell signaling by SARS-CoV-2. Trends Microbiol. (2021) 29:224&#x2013;37. doi:&#xa0;10.1016/j.tim.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7836829</ArticleId><ArticleId IdType="pubmed">33451855</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Zhang X, Wang F, Wang P, Kuang E, Li X. Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2. BioRxiv. (2020). doi:&#xa0;10.1101/2020.08.12.247767</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.12.247767</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee AK, Blanco MR, Bruce EA, Honson DD, Chen LM, Chow A, et al. . SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell. (2020) 183:1325&#x2013;1339.e21. doi:&#xa0;10.1016/j.cell.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndrome: Clin Res Rev. (2020) 14:407&#x2013;12. doi:&#xa0;10.1016/j.dsx.2020.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Huang Y, Ge J, Liu Z, Lu P, Huang B, et al. . A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. Cell. (2022) 185:4347&#x2013;4360.e17. doi:&#xa0;10.1016/j.cell.2022.09.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.037</ArticleId><ArticleId IdType="pmc">PMC9531661</ArticleId><ArticleId IdType="pubmed">36335936</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogstam A, Nyblom M, Christensen S, Sele C, Talibov VO, Lindvall T, et al. . Crystal structure of non-structural protein 10 from severe acute respiratory syndrome coronavirus-2. Int J Mol Sci. (2020) 21:7375. doi:&#xa0;10.3390/ijms21197375</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197375</ArticleId><ArticleId IdType="pmc">PMC7583907</ArticleId><ArticleId IdType="pubmed">33036230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol. (2022) 52:123&#x2013;34. doi:&#xa0;10.1016/j.coviro.2021.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8642146</ArticleId><ArticleId IdType="pubmed">34915287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu JC-C, Laurent-Rolle M, Pawlak JB, Wilen CB, Cresswell P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc Natl Acad Sci. (2021) 118:e2101161118. doi:&#xa0;10.1073/pnas.2101161118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101161118</ArticleId><ArticleId IdType="pmc">PMC8214666</ArticleId><ArticleId IdType="pubmed">34045361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadhave K, Kumar P, Kumar A, Bhardwaj T, Garg N, Giri R. Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions. Microbial Pathogenesis. (2021) 158:105041. doi:&#xa0;10.1016/j.micpath.2021.105041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105041</ArticleId><ArticleId IdType="pmc">PMC8191288</ArticleId><ArticleId IdType="pubmed">34119626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Ge J, Zheng L, Zhang Y, Gao Y, Wang T, et al. . Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis. Cell. (2021) 184:184&#x2013;193.e10. doi:&#xa0;10.1016/j.cell.2020.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.016</ArticleId><ArticleId IdType="pmc">PMC7666536</ArticleId><ArticleId IdType="pubmed">33232691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Zhou Z, Xiao X, Tian Z, Dong X, Wang C, et al. . SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell Mol Immunol. (2021) 18:945&#x2013;53. doi:&#xa0;10.1038/s41423-020-00619-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00619-y</ArticleId><ArticleId IdType="pmc">PMC7907794</ArticleId><ArticleId IdType="pubmed">33637958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Malone B, Llewellyn E, Grasso M, Shelton PM, Olinares PDB, et al. . Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex. Cell. (2020) 182:1560&#x2013;1573.e13. doi:&#xa0;10.1016/j.cell.2020.07.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.033</ArticleId><ArticleId IdType="pmc">PMC7386476</ArticleId><ArticleId IdType="pubmed">32783916</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T, Huang M, Wu D, Ren Y, Zhang X, Han Y, et al. . SARS-coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts. Virologica Sin. (2020) 35:321&#x2013;9. doi:&#xa0;10.1007/s12250-020-00242-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00242-1</ArticleId><ArticleId IdType="pmc">PMC7271831</ArticleId><ArticleId IdType="pubmed">32500504</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez C, Swanson SE, Negatu SG, Dittmar M, Miller J, Ramage HR, et al. . SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PloS One. (2021) 16:e0253089. doi:&#xa0;10.1371/journal.pone.0253089</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253089</ArticleId><ArticleId IdType="pmc">PMC8224853</ArticleId><ArticleId IdType="pubmed">34166398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogando NS, Zevenhoven-Dobbe JC, van Der Meer Y, Bredenbeek PJ, Posthuma CC, Snijder EJ. The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol. (2020) 94. doi:&#xa0;10.1128/jvi.01246-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01246-20</ArticleId><ArticleId IdType="pmc">PMC7654266</ArticleId><ArticleId IdType="pubmed">32938769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen C-K, Lam J-Y, Wong W-M, Mak L-F, Wang X, Chu H, et al. . SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerging Microbes infections. (2020) 9:1418&#x2013;28. doi:&#xa0;10.1080/22221751.2020.1780953</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1780953</ArticleId><ArticleId IdType="pmc">PMC7473193</ArticleId><ArticleId IdType="pubmed">32529952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayn M, Hirschenberger M, Koepke L, Nchioua R, Straub JH, Klute S, et al. . Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities. Cell Rep. (2021) 35:109126. doi:&#xa0;10.1016/j.celrep.2021.109126</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109126</ArticleId><ArticleId IdType="pmc">PMC8078906</ArticleId><ArticleId IdType="pubmed">33974846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackbart M, Deng X, Baker SC. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proc Natl Acad Sci. (2020) 117:8094&#x2013;103. doi:&#xa0;10.1073/pnas.1921485117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1921485117</ArticleId><ArticleId IdType="pmc">PMC7149396</ArticleId><ArticleId IdType="pubmed">32198201</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. New Engl J Med. (2020) 383:2255&#x2013;73. doi:&#xa0;10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Krafcikova P, Silhan J, Nencka R, Boura E. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun. (2020) 11:3717. doi:&#xa0;10.1038/s41467-020-17495-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17495-9</ArticleId><ArticleId IdType="pmc">PMC7381658</ArticleId><ArticleId IdType="pubmed">32709887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern DM, Sorum B, Mali SS, Hoel CM, Sridharan S, Remis JP, et al. et al. . Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs. Nat Struct Mol Biol. (2021) 28:573&#x2013;82. doi:&#xa0;10.1038/s41594-021-00619-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00619-0</ArticleId><ArticleId IdType="pmc">PMC8772433</ArticleId><ArticleId IdType="pubmed">34158638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Zheng Q, Sun L, Ji M, Li Y, Deng H, Zhang H, et al. et al. . ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress. Dev Cell. (2021) 56:3250&#x2013;3263.e5. doi:&#xa0;10.1016/j.devcel.2021.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8502680</ArticleId><ArticleId IdType="pubmed">34706264</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G, Zhao H, Li Y, Ji M, Chen Y, Shi Y, Bi Y, et al. . ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev Cell. (2021) 56:427&#x2013;442.e5. doi:&#xa0;10.1016/j.devcel.2020.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.12.010</ArticleId><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M, et al. . The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol. (2020) 17:881&#x2013;3. doi:&#xa0;10.1038/s41423-020-0485-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0485-9</ArticleId><ArticleId IdType="pmc">PMC7301057</ArticleId><ArticleId IdType="pubmed">32555321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang L, Cheng G. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. Mol Ther. (2022) 30:1869&#x2013;84. doi:&#xa0;10.1016/j.ymthe.2022.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2022.02.014</ArticleId><ArticleId IdType="pmc">PMC8842579</ArticleId><ArticleId IdType="pubmed">35176485</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurme A, Jalkanen P, Heroum J, Liedes O, Vara S, Melin M, et al. . Long-lasting T cell responses in BNT162b2 COVID-19 mRNA vaccinees and COVID-19 convalescent patients. Front Immunol. (2022) 13:869990. doi:&#xa0;10.3389/fimmu.2022.869990</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.869990</ArticleId><ArticleId IdType="pmc">PMC9073085</ArticleId><ArticleId IdType="pubmed">35529867</ArticleId></ArticleIdList></Reference><Reference><Citation>Azad GK, Khan PK. Variations in Orf3a protein of SARS-CoV-2 alter its structure and function. Biochem biophysics Rep. (2021) 26:100933. doi:&#xa0;10.1016/j.bbrep.2021.100933</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2021.100933</ArticleId><ArticleId IdType="pmc">PMC7839395</ArticleId><ArticleId IdType="pubmed">33527091</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno Y, Kimura I, Uriu K, Fukushi M, Irie T, Koyanagi Y, et al. . SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant. Cell Rep. (2020) 32. doi:&#xa0;10.1101/2020.05.11.088179</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.11.088179</ArticleId><ArticleId IdType="pmc">PMC7473339</ArticleId><ArticleId IdType="pubmed">32941788</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. (2020) 92:589&#x2013;94. doi:&#xa0;10.1002/jmv.25725</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25725</ArticleId><ArticleId IdType="pmc">PMC7228294</ArticleId><ArticleId IdType="pubmed">32100876</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-Y, Liao C.-H, Wang Q, Tan Y.-J, Luo R, Qiu Y, et al. . The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res. (2020) 286:198074. doi:&#xa0;10.1016/j.virusres.2020.198074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198074</ArticleId><ArticleId IdType="pmc">PMC7309931</ArticleId><ArticleId IdType="pubmed">32589897</ArticleId></ArticleIdList></Reference><Reference><Citation>Miorin L, Kehrer T, Sanchez-Aparicio MT, Zhang K, Cohen P, Patel RS, et al. et al. . SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci. (2020) 117:28344&#x2013;54. doi:&#xa0;10.1073/pnas.2016650117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016650117</ArticleId><ArticleId IdType="pmc">PMC7668094</ArticleId><ArticleId IdType="pubmed">33097660</ArticleId></ArticleIdList></Reference><Reference><Citation>Addetia A, Lieberman NA, Phung Q, Hsiang T-Y, Xie H, Roychoudhury P, et al. . SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98. MBio. (2021) 12. doi:&#xa0;10.1128/mbio.00065-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00065-21</ArticleId><ArticleId IdType="pmc">PMC8092196</ArticleId><ArticleId IdType="pubmed">33849972</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z, Xia H, Rajsbaum R, Xia X, Wang H, Shi P-Y, et al. . Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response. Cell Mol Immunol. (2021) 18:746&#x2013;8. doi:&#xa0;10.1038/s41423-020-00603-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00603-6</ArticleId><ArticleId IdType="pmc">PMC7815971</ArticleId><ArticleId IdType="pubmed">33473190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, et al. . Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes. IScience. (2021) 24. doi:&#xa0;10.1016/j.isci.2021.102187</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102187</ArticleId><ArticleId IdType="pmc">PMC7879101</ArticleId><ArticleId IdType="pubmed">33615195</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Lam J-Y, Wong W-M, Yuen C-K, Cai J-P, Au S, et al. . Accurate diagnosis of COVID-19 by a novel immunogenic secreted SARS-CoV-2 orf8 protein. MBio. (2020) 11. doi:&#xa0;10.1128/mbio.02431-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02431-20</ArticleId><ArticleId IdType="pmc">PMC7587431</ArticleId><ArticleId IdType="pubmed">33082264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid F, Dzakah EE, Wang H, Tang S. The ORF8 protein of SARS-CoV-2 induced endoplasmic reticulum stress and mediated immune evasion by antagonizing production of interferon beta. Virus Res. (2021) 296:198350. doi:&#xa0;10.1016/j.virusres.2021.198350</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198350</ArticleId><ArticleId IdType="pmc">PMC7897408</ArticleId><ArticleId IdType="pubmed">33626380</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng H, Subramanian S, Wu L, Bu H.-F, Wang X, Du C, et al. . SARS-CoV-2 ORF8 forms intracellular aggregates and inhibits IFN&#x3b3;-induced antiviral gene expression in human lung epithelial cells. Front Immunol. (2021) 12:679482. doi:&#xa0;10.3389/fimmu.2021.679482</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.679482</ArticleId><ArticleId IdType="pmc">PMC8221109</ArticleId><ArticleId IdType="pubmed">34177923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Chen Y, Li Y, Huang F, Luo B, Yuan Y, et al. . The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-I. Proc Natl Acad Sci. (2021) 118:e2024202118. doi:&#xa0;10.1073/pnas.2024202118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024202118</ArticleId><ArticleId IdType="pmc">PMC8201919</ArticleId><ArticleId IdType="pubmed">34021074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirera P&#xe9;rez R. Las nuevas variantes del SARS-CoV-2 que nadie busca y que est&#xe1;n haciendo al virus m&#xe1;s resistente a la respuesta inmunitaria. Inmunolog&#xed;a. (2021) 40:14&#x2013;21.</Citation></Reference><Reference><Citation>Lin X, Fu B, Yin S, Li Z, Liu H, Zhang H, et al. . ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. Iscience. (2021) 24. doi:&#xa0;10.1016/j.isci.2021.102293</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102293</ArticleId><ArticleId IdType="pmc">PMC7942160</ArticleId><ArticleId IdType="pubmed">33723527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Shi Y, Pan X, Wu S, Hou R, Zhang Y, et al. . SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO. Cell Rep. (2021) 34. doi:&#xa0;10.1016/j.celrep.2021.108761</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108761</ArticleId><ArticleId IdType="pmc">PMC7857071</ArticleId><ArticleId IdType="pubmed">33567255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Zhu K, Qin B, Olieric V, Wang M, Cui S. Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions. Nat Commun. (2021) 12:2843. doi:&#xa0;10.1038/s41467-021-23118-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23118-8</ArticleId><ArticleId IdType="pmc">PMC8121815</ArticleId><ArticleId IdType="pubmed">33990585</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhuang MW, Deng J, Zheng Y, Zhang J, Nan ML, et al. . SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5&#x2013;MAVS, TLR3&#x2013;TRIF, and cGAS&#x2013;STING signaling pathways. J Med Virol. (2021) 93:5376&#x2013;89. doi:&#xa0;10.1002/jmv.27050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez Andres A, Feng Y, Campos A.R, Yin J, Yang C-C, James B, et al. . SARS-CoV-2 ORF9c is a membrane-associated protein that suppresses antiviral responses in cells. BioRxiv. (2020). doi:&#xa0;10.1101/2020.08.18.256776</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.18.256776</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Hou P, Ma W, Wang X, Wang H, Yu Z, et al. . SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy. Cell Mol Immunol. (2022) 19:67&#x2013;78. doi:&#xa0;10.1038/s41423-021-00807-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00807-4</ArticleId><ArticleId IdType="pmc">PMC8628139</ArticleId><ArticleId IdType="pubmed">34845370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JFW, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. (2020) 9:221&#x2013;36. doi:&#xa0;10.1080/22221751.2020.1719902</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1719902</ArticleId><ArticleId IdType="pmc">PMC7067204</ArticleId><ArticleId IdType="pubmed">31987001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan SR, Spratt AN, Sharma K, Chand HS, Byrareddy SN, Singh K. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies. J Autoimmun. (2022) 126:102779. doi:&#xa0;10.1016/j.jaut.2021.102779</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102779</ArticleId><ArticleId IdType="pmc">PMC8666303</ArticleId><ArticleId IdType="pubmed">34915422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-specific immune response and the pathogenesis of COVID-19. Int J Mol Sci. (2022) 23(3):1716. doi:&#xa0;10.3390/ijms23031716</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Vanstreels E, Jansen S, Daelemans D. Cellular host factors for SARS-CoV-2 infection. Nat Microbiol. (2021) 6:1219&#x2013;32. doi:&#xa0;10.1038/s41564-021-00958-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00958-0</ArticleId><ArticleId IdType="pubmed">34471255</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Guo M, Tian X, Wang X, Yang X, Wu P, et al. . Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med. (2021) 2:99&#x2013;112 e7. doi:&#xa0;10.1016/j.medj.2020.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7373048</ArticleId><ArticleId IdType="pubmed">32838362</ArticleId></ArticleIdList></Reference><Reference><Citation>Papanikolaou V, Chrysovergis A, Ragos V, Tsiambas E, Katsinis S, Manoli A, et al. . From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants. Gene. (2022) 814:146134. doi:&#xa0;10.1016/j.gene.2021.146134</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2021.146134</ArticleId><ArticleId IdType="pmc">PMC8725615</ArticleId><ArticleId IdType="pubmed">34990799</ArticleId></ArticleIdList></Reference><Reference><Citation>Redondo N, Zald&#xed;var-L&#xf3;pez S, Garrido JJ, Montoya M. SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns. Front Immunol. (2021) 12:708264. doi:&#xa0;10.3389/fimmu.2021.708264</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708264</ArticleId><ArticleId IdType="pmc">PMC8293742</ArticleId><ArticleId IdType="pubmed">34305949</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MR, Easthausen I, Gallagher G, Udupa J, Tong Y, Torigian D, et al. . Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study. Thorax. (2020) 75:801&#x2013;4. doi:&#xa0;10.1136/thoraxjnl-2019-214461</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2019-214461</ArticleId><ArticleId IdType="pmc">PMC7888552</ArticleId><ArticleId IdType="pubmed">32482837</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik JR, Acharya A, Avedissian SN, Byrareddy SN, Fletcher CV, Podany AT, et al. . ACE-2, TMPRSS2, and neuropilin-1 receptor expression on human brain astrocytes and pericytes and SARS-CoV-2 infection kinetics. Int J Mol Sci. (2023) 24(10):8622. doi:&#xa0;10.3390/ijms24108622</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108622</ArticleId><ArticleId IdType="pmc">PMC10218482</ArticleId><ArticleId IdType="pubmed">37239978</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Wang Y, Xu D, Xiao L, Qin W, Liu B, et al. . Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy. Front Genet. (2022) 13:995736. doi:&#xa0;10.3389/fgene.2022.995736</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.995736</ArticleId><ArticleId IdType="pmc">PMC9627153</ArticleId><ArticleId IdType="pubmed">36338984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins C, Lechien JR, Saussez S. More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. (2021) 146:110406. doi:&#xa0;10.1016/j.mehy.2020.110406</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110406</ArticleId><ArticleId IdType="pmc">PMC7678428</ArticleId><ArticleId IdType="pubmed">33246692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Li W, Feng J, Ramos da Silva S, Ju E, Zhang H, et al. . SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. J Med Virol. (2021) 93:6671&#x2013;85. doi:&#xa0;10.1002/jmv.27244</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27244</ArticleId><ArticleId IdType="pmc">PMC8426707</ArticleId><ArticleId IdType="pubmed">34324210</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, et al. . SARS-CoV-2: receptor and co-receptor tropism probability. Curr Microbiol. (2022) 79:133. doi:&#xa0;10.1007/s00284-022-02807-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-022-02807-7</ArticleId><ArticleId IdType="pmc">PMC8923825</ArticleId><ArticleId IdType="pubmed">35292865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukassen S, Chua R.L, Trefzer T, Kahn NC, Schneider MA, Muley T, et al. . SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. EMBO J. (2020) 39:e105114. doi:&#xa0;10.15252/embj.2020105114</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105114</ArticleId><ArticleId IdType="pmc">PMC7232010</ArticleId><ArticleId IdType="pubmed">32246845</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Maglio M, Landini MP, Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne). (2020) 7:594495. doi:&#xa0;10.3389/fmed.2020.594495</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.594495</ArticleId><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Internal Med. (2020) 76:14&#x2013;20. doi:&#xa0;10.1016/j.ejim.2020.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.04.037</ArticleId><ArticleId IdType="pmc">PMC7167588</ArticleId><ArticleId IdType="pubmed">32336612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. cell. (2020) 181:271&#x2013;280.e8. doi:&#xa0;10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, et al. . Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci. (2020) 117:7001&#x2013;3. doi:&#xa0;10.1073/pnas.2002589117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2002589117</ArticleId><ArticleId IdType="pmc">PMC7132130</ArticleId><ArticleId IdType="pubmed">32165541</ArticleId></ArticleIdList></Reference><Reference><Citation>Birra D, Benucci M, Landolfi L, Merchionda A, Loi G, Amato P, et al. . COVID 19: a clue from innate immunity. Immunologic Res. (2020) 68:161&#x2013;8. doi:&#xa0;10.1007/s12026-020-09137-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09137-5</ArticleId><ArticleId IdType="pmc">PMC7286633</ArticleId><ArticleId IdType="pubmed">32524333</ArticleId></ArticleIdList></Reference><Reference><Citation>Madden EA, Diamond MS. Host cell-intrinsic innate immune recognition of SARS-CoV-2. Curr Opin Virol. (2022) 52:30&#x2013;8. doi:&#xa0;10.1016/j.coviro.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8580835</ArticleId><ArticleId IdType="pubmed">34814102</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Diamond MS. The immunology and immunopathology of COVID-19. Science. (2022) 375:1122&#x2013;7. doi:&#xa0;10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheemarla NR, Watkins TA, Mihaylova VT, Wang B, Zhao D, Wang G, et al. . Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. J Exp Med. (2021) 218(8):e20210583. doi:&#xa0;10.1084/jem.20210583</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210583</ArticleId><ArticleId IdType="pmc">PMC8210587</ArticleId><ArticleId IdType="pubmed">34128960</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, Sapra L, Saini C, Azam Z, Mishra PK, Verma B, et al. . COVID-19: immunology, immunopathogenesis and potential therapies. Int Rev Immunol. (2022) 41:171&#x2013;206. doi:&#xa0;10.1080/08830185.2021.1883600</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830185.2021.1883600</ArticleId><ArticleId IdType="pmc">PMC7919479</ArticleId><ArticleId IdType="pubmed">33641587</ArticleId></ArticleIdList></Reference><Reference><Citation>Land WG. Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia. Genes Immun. (2021) 22:141&#x2013;60. doi:&#xa0;10.1038/s41435-021-00140-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-021-00140-w</ArticleId><ArticleId IdType="pmc">PMC8210526</ArticleId><ArticleId IdType="pubmed">34140652</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Strobbe D, Campanella M. Pyroptosis targeting via mitochondria: An educated guess to innovate COVID-19 therapies. Br J Pharmacol. (2022) 179:2081&#x2013;5. doi:&#xa0;10.1111/bph.15670</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15670</ArticleId><ArticleId IdType="pmc">PMC8653109</ArticleId><ArticleId IdType="pubmed">34632567</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. (2020) 20:363&#x2013;74. doi:&#xa0;10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill AR, Khalil R, Dutta R, Green R, Howell M, Mohapatra S, et al. . SARS-CoV-2 immuno-pathogenesis and potential for diverse vaccines and therapies:&#xa0;opportunities and challenges. Infect Dis Rep. (2021) 13:102&#x2013;25. doi:&#xa0;10.3390/idr13010013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr13010013</ArticleId><ArticleId IdType="pmc">PMC7931091</ArticleId><ArticleId IdType="pubmed">33557330</ArticleId></ArticleIdList></Reference><Reference><Citation>Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, et al. . Rationale for targeting complement in COVID-19. EMBO Mol Med. (2020) 12:e12642. doi:&#xa0;10.15252/emmm.202012642</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012642</ArticleId><ArticleId IdType="pmc">PMC7323084</ArticleId><ArticleId IdType="pubmed">32559343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong NA, Saier MH, Jr. The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis. Int J Mol Sci. (2021) 22:1308. doi:&#xa0;10.3390/ijms22031308</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031308</ArticleId><ArticleId IdType="pmc">PMC7865831</ArticleId><ArticleId IdType="pubmed">33525632</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B, Noris M, Lambrecht BN, Kemper C. The state of complement in COVID-19. Nat Rev Immunol. (2022) 22:77&#x2013;84. doi:&#xa0;10.1038/s41577-021-00665-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00665-1</ArticleId><ArticleId IdType="pmc">PMC8672651</ArticleId><ArticleId IdType="pubmed">34912108</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosroshahi LM, Rokni M, Mokhtari T, Noorbakhsh F. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. Int Immunopharmacol. (2021) 93:107364. doi:&#xa0;10.1016/j.intimp.2020.107364</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107364</ArticleId><ArticleId IdType="pmc">PMC7784533</ArticleId><ArticleId IdType="pubmed">33486333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. (2021) 88:15&#x2013;27. doi:&#xa0;10.1159/000512007</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512007</ArticleId><ArticleId IdType="pmc">PMC7649697</ArticleId><ArticleId IdType="pubmed">33049751</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, et al. . Untimely TGFbeta responses in COVID-19 limit antiviral functions of NK cells. Nature. (2021) 600:295&#x2013;301. doi:&#xa0;10.1038/s41586-021-04142-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology. (2021) 27:423&#x2013;37. doi:&#xa0;10.1016/j.pulmoe.2021.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC8040543</ArticleId><ArticleId IdType="pubmed">33867315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlei M, Sidorov IA, Joosten SA, Heemskerk MH, Myeni SK, Pothast CR, et al. . Immune determinants of viral clearance in hospitalised COVID-19 patients: reduced circulating naive CD4+ T cell counts correspond with delayed viral clearance. Cells. (2022) 11. doi:&#xa0;10.3390/cells11172743</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11172743</ArticleId><ArticleId IdType="pmc">PMC9455062</ArticleId><ArticleId IdType="pubmed">36078151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. (2021) 184:861&#x2013;80. doi:&#xa0;10.1016/j.cell.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. (2021) 33:155&#x2013;62. doi:&#xa0;10.1097/BOR.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Trans Sci. (2021) 14:898&#x2013;907. doi:&#xa0;10.1111/cts.12953</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12953</ArticleId><ArticleId IdType="pmc">PMC8212749</ArticleId><ArticleId IdType="pubmed">33306235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y, et al. . The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. (2021) 20:102792. doi:&#xa0;10.1016/j.autrev.2021.102792</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. . Distinguishing features of long COVID identified through immune profiling. Nature. (2023) 623:139&#x2013;48. doi:&#xa0;10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertiwi D, Hafiz I, Illian DN. Dendritic cell-based COVID-19 vaccines: A mini review. Clin trials. (2021) 6:9. doi:&#xa0;10.29228/jrp.78</Citation><ArticleIdList><ArticleId IdType="doi">10.29228/jrp.78</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. (2021) 93:250&#x2013;6. doi:&#xa0;10.1002/jmv.26232</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. (2020) 11:1708. doi:&#xa0;10.3389/fimmu.2020.01708</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharra R, Sharma AK, Datta S. Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects. Cytokine. (2023) 156287. doi:&#xa0;10.1016/j.cyto.2023.156287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2023.156287</ArticleId><ArticleId IdType="pmc">PMC10291296</ArticleId><ArticleId IdType="pubmed">37402337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerla L, Moitra S, Pink D, Govindasamy N, Duchesne M, Reklow E, et al. . SARS-CoV-2-induced TSLP is associated with duration of hospital stay in COVID-19 patients. Viruses. (2023) 15:556. doi:&#xa0;10.3390/v15020556</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020556</ArticleId><ArticleId IdType="pmc">PMC9959394</ArticleId><ArticleId IdType="pubmed">36851770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. (2020) 55:105924. doi:&#xa0;10.1016/j.ijantimicag.2020.105924</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu M. Clinical features of cytokine storm syndrome. In: Cytokine storm syndrome (2019). p. 31&#x2013;41.</Citation></Reference><Reference><Citation>Niessl J, Sekine T, Buggert M. T cell immunity to SARS-CoV-2. In: Seminars in immunology. Elsevier; (2021) 55:101505. doi:&#xa0;10.1016/j.smim.2021.101505</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2021.101505</ArticleId><ArticleId IdType="pmc">PMC8529278</ArticleId><ArticleId IdType="pubmed">34711489</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelow B, Mao T, Klein J, Song E, Menasche B, Omer SB, et al. . Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. bioRxiv. (2021). doi:&#xa0;10.1101/2021.05.19.444825</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.19.444825</ArticleId><ArticleId IdType="pmc">PMC9047536</ArticleId><ArticleId IdType="pubmed">34623900</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan K, Yu J, Mercado NB, Loos C, Tostanoski LH, Chandrashekar A, et al. . Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. (2021) 590:630&#x2013;4. doi:&#xa0;10.1038/s41586-020-03041-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03041-6</ArticleId><ArticleId IdType="pmc">PMC7906955</ArticleId><ArticleId IdType="pubmed">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarbartolo S, Ranzani V, Bandera A, Gruarin P, Bevilacqua V, Putignano AR, et al. . Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. Sci Immunol. (2021) 6. doi:&#xa0;10.1126/sciimmunol.abg5021</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abg5021</ArticleId><ArticleId IdType="pubmed">34376481</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CY, Lim JM, et al. . Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med. (2021) 218. doi:&#xa0;10.1084/jem.20202617</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202617</ArticleId><ArticleId IdType="pmc">PMC7927662</ArticleId><ArticleId IdType="pubmed">33646265</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss P. The T cell immune response against SARS-CoV-2. Nat Immunol. (2022) 23:186&#x2013;93. doi:&#xa0;10.1038/s41590-021-01122-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01122-w</ArticleId><ArticleId IdType="pubmed">35105982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng C, Evans JP, King T, Zheng Y-M, Oltz EM, Whelan SP, et al. . SARS-CoV-2 spreads through cell-to-cell transmission. Proc Natl Acad Sci. (2022) 119:e2111400119. doi:&#xa0;10.1073/pnas.2111400119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2111400119</ArticleId><ArticleId IdType="pmc">PMC8740724</ArticleId><ArticleId IdType="pubmed">34937699</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderbacher CR, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. . Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. (2020) 183:996&#x2013;1012 e19. doi:&#xa0;10.1016/j.cell.2020.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.038</ArticleId><ArticleId IdType="pmc">PMC7494270</ArticleId><ArticleId IdType="pubmed">33010815</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E-C, Jung JH, Rha M-S, Sa M, Choi HK, Jeon JH, et al. . SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescents for 8 months with successful development of stem cell-like memory T cells. (preprint). (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245549</ArticleId><ArticleId IdType="pubmed">34193870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JH, Rha M.-S, Sa M, Choi HK, Jeon JH, Seok H, et al. . SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells. Nat Commun. (2021) 12:4043. doi:&#xa0;10.1038/s41467-021-24377-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24377-1</ArticleId><ArticleId IdType="pmc">PMC8245549</ArticleId><ArticleId IdType="pubmed">34193870</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H. Microglia-mediated neuroinflammation: A potential target for the treatment of cardiovascular diseases. J Inflammation Res. (2022) 15:3083&#x2013;94. doi:&#xa0;10.2147/JIR.S350109</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S350109</ArticleId><ArticleId IdType="pmc">PMC9148574</ArticleId><ArticleId IdType="pubmed">35642214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z-w, Zhang H.-z, Liu C, Dong K. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. (2021) 20:102754. doi:&#xa0;10.1016/j.autrev.2021.102754</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102754</ArticleId><ArticleId IdType="pmc">PMC7813482</ArticleId><ArticleId IdType="pubmed">33476817</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res. (2021) 26:1&#x2013;9. doi:&#xa0;10.1186/s40001-021-00563-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00563-1</ArticleId><ArticleId IdType="pmc">PMC8329616</ArticleId><ArticleId IdType="pubmed">34344463</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi M, Pandey N, Shukla A, Singh SK. SARS coronavirus 2: from genome to infectome. Respir Res. (2020) 21:318. doi:&#xa0;10.1186/s12931-020-01581-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01581-z</ArticleId><ArticleId IdType="pmc">PMC7706175</ArticleId><ArticleId IdType="pubmed">33261606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Sidney J, Crotty S. T cell responses to SARS-CoV-2. Annu Rev Immunol. (2023) 41:343&#x2013;73. doi:&#xa0;10.1146/annurev-immunol-101721-061120</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101721-061120</ArticleId><ArticleId IdType="pubmed">36750314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. . Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. (2021) 371. doi:&#xa0;10.1126/science.abf4063</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A, Sidney J, Vita R, Peters B, Crotty S, Weiskopf D, et al. . SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19. Cell Host Microbe. (2021) 29:1076&#x2013;92. doi:&#xa0;10.1016/j.chom.2021.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8139264</ArticleId><ArticleId IdType="pubmed">34237248</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto JA, Melo-Gonz&#xe1;lez F, Gutierrez-Vera C, Schultz BM, Berr&#xed;os-Rojas RV, Rivera-P&#xe9;rez D, et al. . Inactivated vaccine-induced SARS-CoV-2 variant-specific immunity in children. mBio. (2022) 13:e0131122. doi:&#xa0;10.1128/mbio.01311-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.01311-22</ArticleId><ArticleId IdType="pmc">PMC9765711</ArticleId><ArticleId IdType="pubmed">36383021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez C, Pe&#xf1;aloza HF, Schultz BM, Pi&#xf1;a-Iturbe A, R&#xed;os M, Moreno-Tapia D, et al. . Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults. EBioMedicine. (2023) 91:104563. doi:&#xa0;10.1016/j.ebiom.2023.104563</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104563</ArticleId><ArticleId IdType="pmc">PMC10129368</ArticleId><ArticleId IdType="pubmed">37099842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz BM, Melo-Gonz&#xe1;lez F, Duarte LF, G&#xe1;lvez NM, Pacheco GA, Soto JA, et al. . A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern. MBio. (2022) 13:e01423&#x2013;22. doi:&#xa0;10.1128/mbio.01423-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.01423-22</ArticleId><ArticleId IdType="pmc">PMC9426482</ArticleId><ArticleId IdType="pubmed">35946814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno SM, Abarca K, Gonz&#xe1;lez PA, G&#xe1;lvez NM, Soto JA, Duarte LF, et al. . Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile. Clin Infect Dis. (2022) 75:e792&#x2013;804. doi:&#xa0;10.1093/cid/ciab823</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab823</ArticleId><ArticleId IdType="pmc">PMC9402626</ArticleId><ArticleId IdType="pubmed">34537835</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvez NM, Pacheco GA, Schultz BM, Melo-Gonz&#xe1;lez F, Soto JA, Duarte LF, et al. . Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. Elife. (2022) 11. doi:&#xa0;10.7554/eLife.81477</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.81477</ArticleId><ArticleId IdType="pmc">PMC9596164</ArticleId><ArticleId IdType="pubmed">36226829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieber F, Allen N, Carpenter K, Hu P, Alagna R, Rao S, et al. . Durability of COVID-19 vaccine induced T-cell mediated immune responses measured using the QuantiFERON SARS-CoV-2 assay. Pulmonology. (2023) 29:151&#x2013;3. doi:&#xa0;10.1016/j.pulmoe.2022.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2022.09.006</ArticleId><ArticleId IdType="pmc">PMC9671490</ArticleId><ArticleId IdType="pubmed">36402704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, et al. . T cell immune memory after covid-19 and vaccination. BMJ Med. (2023) 2:e000468. doi:&#xa0;10.1136/bmjmed-2022-000468</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000468</ArticleId><ArticleId IdType="pmc">PMC10668147</ArticleId><ArticleId IdType="pubmed">38027416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, et al. . T cell immune memory after covid-19 and vaccination. BMJ Medicine. (2023) 2(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10668147</ArticleId><ArticleId IdType="pubmed">38027416</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds CJ, Gibbons JM, Pade C, Lin K.-M, Sandoval DM, Pieper F, et al. . Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science. (2022) 375:183&#x2013;92. doi:&#xa0;10.1126/science.abm0811</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm0811</ArticleId><ArticleId IdType="pmc">PMC10186585</ArticleId><ArticleId IdType="pubmed">34855510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Li K, Mei X, Cao J, Zhong J, Huang P, et al. . SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants. Cell Discovery. (2022) 8:136. doi:&#xa0;10.1038/s41421-022-00501-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00501-3</ArticleId><ArticleId IdType="pmc">PMC9769462</ArticleId><ArticleId IdType="pubmed">36543767</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination: the end of the beginning. Annu Rev Pathology: Mech Dis. (2024) 19:69&#x2013;97. doi:&#xa0;10.1146/annurev-pathmechdis-031521-042754</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-031521-042754</ArticleId><ArticleId IdType="pubmed">37738512</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzymski P, Pokorska-&#x15a;piewak M, Jackowska T, Kuchar E, Nitsch-Osuch A, Paw&#x142;owska M, et al. . Key considerations during the transition from the acute phase of the COVID-19 pandemic: A narrative review. Vaccines (Basel). (2023) 11. doi:&#xa0;10.3390/vaccines11091502</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11091502</ArticleId><ArticleId IdType="pmc">PMC10537111</ArticleId><ArticleId IdType="pubmed">37766178</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Madewell ZJ, Liu M, Miao Y, Xiang S, Huo Y, et al. . A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants. Vaccine. (2024). doi:&#xa0;10.1016/j.vaccine.2024.04.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.04.049</ArticleId><ArticleId IdType="pubmed">38653679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N, Joyal-Desmarais K, Ribeiro PA, Vieira AM, Stojanovic J, Sanuade C, et al. . Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. (2023) 11:439&#x2013;52. doi:&#xa0;10.1016/S2213-2600(23)00015-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00015-2</ArticleId><ArticleId IdType="pmc">PMC9917454</ArticleId><ArticleId IdType="pubmed">36780914</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. (2021) 325:1525&#x2013;34. doi:&#xa0;10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. (2022) 28:911&#x2013;23. doi:&#xa0;10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2023) 401:e21&#x2013;33. doi:&#xa0;10.1016/S0140-6736(23)00810-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial lung disease and pulmonary fibrosis: a practical approach for general medicine physicians with focus on the medical history. J Clin Med. (2018) 7:476. doi:&#xa0;10.3390/jcm7120476</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120476</ArticleId><ArticleId IdType="pmc">PMC6306719</ArticleId><ArticleId IdType="pubmed">30477216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechowicz K, Dro&#x17c;d&#x17c;al S, Machaj F, Rosik J, Szostak B, Zegan-Bara&#x144;ska M, et al. . COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection. J Clin Med. (2020) 9:1917. doi:&#xa0;10.3390/jcm9061917</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061917</ArticleId><ArticleId IdType="pmc">PMC7356800</ArticleId><ArticleId IdType="pubmed">32575380</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd NW, Luzina IG, Atamas SP. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. (2012) 5:1&#x2013;24. doi:&#xa0;10.1186/1755-1536-5-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-5-11</ArticleId><ArticleId IdType="pmc">PMC3443459</ArticleId><ArticleId IdType="pubmed">22824096</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J-W, Rizzo S, Ma L-H, Qiu X-Y, Warth A, Seki N, et al. . Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology. Trans Lung Cancer Res. (2017) 6:68. doi:&#xa0;10.21037/tlcr</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tlcr</ArticleId><ArticleId IdType="pmc">PMC5344841</ArticleId><ArticleId IdType="pubmed">28331826</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res. (2017) 143:142&#x2013;50. doi:&#xa0;10.1016/j.antiviral.2017.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5507769</ArticleId><ArticleId IdType="pubmed">28390872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambardar SR, Hightower SL, Huprikar NA, Chung KK, Singhal A, Collen JF. Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic. J Clin Med. (2021) 10:2452. doi:&#xa0;10.3390/jcm10112452</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112452</ArticleId><ArticleId IdType="pmc">PMC8199255</ArticleId><ArticleId IdType="pubmed">34205928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. (2020) 16:308&#x2013;10. doi:&#xa0;10.1038/s41581-020-0284-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-0284-7</ArticleId><ArticleId IdType="pmc">PMC7144544</ArticleId><ArticleId IdType="pubmed">32273593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. (2020) 52:345&#x2013;53. doi:&#xa0;10.1080/07853890.2020.1790643</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2020.1790643</ArticleId><ArticleId IdType="pmc">PMC7877945</ArticleId><ArticleId IdType="pubmed">32643418</ArticleId></ArticleIdList></Reference><Reference><Citation>Armaly Z, Kinaneh S, Skorecki K. Renal manifestations of Covid-19: physiology and pathophysiology. J Clin Med. (2021) 10:1216. doi:&#xa0;10.3390/jcm10061216</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10061216</ArticleId><ArticleId IdType="pmc">PMC8000200</ArticleId><ArticleId IdType="pubmed">33804075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf O, Young M, Malik KJ, Cheema T. Systemic complications of COVID-19. Crit Care Nurs Q. (2020) 43:390&#x2013;9. doi:&#xa0;10.1097/CNQ.0000000000000324</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CNQ.0000000000000324</ArticleId><ArticleId IdType="pubmed">32833775</ArticleId></ArticleIdList></Reference><Reference><Citation>Paghdar S, Khan TM, Patel NP, Chandrasekaran S, De Sousa JFM, Tsouklidis N, et al. . Doxycycline therapy for abdominal aortic aneurysm: inhibitory effect on matrix metalloproteinases. Cureus. (2021) 13. doi:&#xa0;10.7759/cureus.14966</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.14966</ArticleId><ArticleId IdType="pmc">PMC8191685</ArticleId><ArticleId IdType="pubmed">34123662</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. (2020) 40:998&#x2013;1004. doi:&#xa0;10.1111/liv.14435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14435</ArticleId><ArticleId IdType="pmc">PMC7228361</ArticleId><ArticleId IdType="pubmed">32170806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. (2020) 5:529&#x2013;30. doi:&#xa0;10.1016/S2468-1253(20)30084-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30084-4</ArticleId><ArticleId IdType="pmc">PMC7270582</ArticleId><ArticleId IdType="pubmed">32203680</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagana SM, Kudose S, Iuga AC, Lee MJ, Fazlollahi L, Remotti HE, et al. . Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Modern Pathol. (2020) 33:2147&#x2013;55. doi:&#xa0;10.1038/s41379-020-00649-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-00649-x</ArticleId><ArticleId IdType="pmc">PMC7424245</ArticleId><ArticleId IdType="pubmed">32792598</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi Y, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer A, et al. . Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection. (2015) 43:495&#x2013;501. doi:&#xa0;10.1007/s15010-015-0720-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-015-0720-y</ArticleId><ArticleId IdType="pmc">PMC4521086</ArticleId><ArticleId IdType="pubmed">25600929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. jama. (2020) 323:1061&#x2013;9. doi:&#xa0;10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. MedRxiv. (2020). doi:&#xa0;10.1101/2020.03.16.20035105</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.16.20035105</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. . Guillain&#x2013;Barr&#xe9; syndrome associated with SARS-CoV-2. New Engl J Med. (2020) 382:2574&#x2013;6. doi:&#xa0;10.1056/NEJMc2009191</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol. (2020) 45:914&#x2013;22. doi:&#xa0;10.1111/coa.13620</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/coa.13620</ArticleId><ArticleId IdType="pmc">PMC7436734</ArticleId><ArticleId IdType="pubmed">32741085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. . Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. (2020). doi:&#xa0;10.1101/2020.02.22.20026500</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.22.20026500</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. . Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect Dis. (2020) 71:889&#x2013;90. doi:&#xa0;10.1093/cid/ciaa330</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein ST, Hashemian SM, Mansourafshar B, Khorram&#x2010;Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. In: International forum of allergy &amp; rhinology. Wiley Online Library; (2020) 10(8):944&#x2013;50. doi:&#xa0;10.1002/alr.22587</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22587</ArticleId><ArticleId IdType="pmc">PMC7262123</ArticleId><ArticleId IdType="pubmed">32301284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Cabaraux P, Chiesa-Estomba CM, Khalife M, Plzak J, Hans S, et al. . Objective olfactory testing in patients presenting with sudden onset olfactory dysfunction as the first manifestation of confirmed COVID-19 infection. Medrxiv. (2020). doi:&#xa0;10.1101/2020.04.15.20066472</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.15.20066472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye R, Chang CD, Kazahaya K, Brereton J, Denneny JC, III. COVID-19 anosmia reporting tool: initial findings. Otolaryngology&#x2013;Head Neck Surg. (2020) 163:132&#x2013;4. doi:&#xa0;10.1177/0194599820922992</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820922992</ArticleId><ArticleId IdType="pubmed">32340555</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. . Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. (2020) 382:1708&#x2013;20. doi:&#xa0;10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, et al. . SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Off J Am Coll Gastroenterology| ACG. (2020) 115:942&#x2013;6. doi:&#xa0;10.14309/ajg.0000000000000667</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000667</ArticleId><ArticleId IdType="pmc">PMC7172485</ArticleId><ArticleId IdType="pubmed">32496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. . Characteristics of COVID-19 infection in Beijing. J infection. (2020) 80:401&#x2013;6. doi:&#xa0;10.1016/j.jinf.2020.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.02.018</ArticleId><ArticleId IdType="pmc">PMC7102527</ArticleId><ArticleId IdType="pubmed">32112886</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. . Clinical characteristics of Covid-19 in New York city. New Engl J Med. (2020) 382:2372&#x2013;4. doi:&#xa0;10.1056/NEJMc2010419</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, et al. . Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. (2020) 95:e2016&#x2013;27. doi:&#xa0;10.1212/WNL.0000000000010116</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010116</ArticleId><ArticleId IdType="pubmed">32546654</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer A, Einan-Lifshitz A, Itah A, Dubinsky-Pertzov B, Pras E, Hecht I, et al. . Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis. Int Ophthalmol. (2021) 41:433&#x2013;40. doi:&#xa0;10.1007/s10792-020-01592-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-020-01592-1</ArticleId><ArticleId IdType="pmc">PMC7489575</ArticleId><ArticleId IdType="pubmed">32929665</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Bartolom&#xe9; F, S&#xe1;nchez-Quir&#xf3;s J. Ocular manifestations of SARS-CoV-2: literature review. Archivos la Sociedad Espa&#xf1;ola Oftalmolog&#xed;a (English Edition). (2021) 96:32&#x2013;40. doi:&#xa0;10.1016/j.oftale.2020.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oftale.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7414418</ArticleId><ArticleId IdType="pubmed">32873480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. (2020) 159:367&#x2013;70. doi:&#xa0;10.1053/j.gastro.2020.03.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.055</ArticleId><ArticleId IdType="pmc">PMC7118654</ArticleId><ArticleId IdType="pubmed">32247022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadi A, Werge M, Kristiansen KT, Pedersen UG, Karstensen JG, Novovic S, et al. . Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: case report on three family members. Pancreatology. (2020) 20:665&#x2013;7. doi:&#xa0;10.1016/j.pan.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pan.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7199002</ArticleId><ArticleId IdType="pubmed">32387082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G, et al. . Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. (2020) 26:367&#x2013;73. doi:&#xa0;10.1093/molehr/gaaa030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/gaaa030</ArticleId><ArticleId IdType="pmc">PMC7239105</ArticleId><ArticleId IdType="pubmed">32365180</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. . Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J obstetrics gynecology MFM. (2020) 2:100107. doi:&#xa0;10.1016/j.ajogmf.2020.100107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100107</ArticleId><ArticleId IdType="pmc">PMC7104131</ArticleId><ArticleId IdType="pubmed">32292902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z, et al. . SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and furin proteases. iScience. (2020) 23:101744. doi:&#xa0;10.1016/j.isci.2020.101744</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101744</ArticleId><ArticleId IdType="pmc">PMC7591870</ArticleId><ArticleId IdType="pubmed">33134888</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, et al. . Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun. (2021) 12:2506. doi:&#xa0;10.1038/s41467-021-22781-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22781-1</ArticleId><ArticleId IdType="pmc">PMC8096808</ArticleId><ArticleId IdType="pubmed">33947851</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D. Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med. (2020) 173:268&#x2013;77. doi:&#xa0;10.7326/L20-1206</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L20-1206</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Liu X, Hu B, Li D, Chen L, Li Y, et al. . Mechanisms of SARS-coV-2 infection-induced kidney injury: A literature review. Front Cell Infect Microbiol. (2022) 12:838213. doi:&#xa0;10.3389/fcimb.2022.838213</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.838213</ArticleId><ArticleId IdType="pmc">PMC9237415</ArticleId><ArticleId IdType="pubmed">35774397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. (2020) 8:738&#x2013;42. doi:&#xa0;10.1016/S2213-2600(20)30229-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30229-0</ArticleId><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel A.S, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395:1417&#x2013;8. doi:&#xa0;10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian JY, Wang B, Lv L-L, Liu B-C. Pathogenesis of acute kidney injury in coronavirus disease 2019. Front Physiol. (2021) 12:586589. doi:&#xa0;10.3389/fphys.2021.586589</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.586589</ArticleId><ArticleId IdType="pmc">PMC7928360</ArticleId><ArticleId IdType="pubmed">33679428</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojo M, Condon J, Whorwood C, Stewart P. Adrenal 11&#x3b2;-hydroxysteroid dehydrogenase. Endocrine Res. (1996) 22:771&#x2013;80. doi:&#xa0;10.1080/07435809609043775</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07435809609043775</ArticleId><ArticleId IdType="pubmed">8969940</ArticleId></ArticleIdList></Reference><Reference><Citation>Akwii RG, Sajib MS, Zahra FT, Mikelis CM. Role of angiopoietin-2 in vascular physiology and pathophysiology. Cells. (2019) 8. doi:&#xa0;10.3390/cells8050471</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050471</ArticleId><ArticleId IdType="pmc">PMC6562915</ArticleId><ArticleId IdType="pubmed">31108880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Sinclair JE, Sadeghirad H, Fraser JF, Short KR, Kulasing A. Cardiovascular disease in SARS-CoV-2 infection. Clin Transl Immunol. (2021) 10:e1343. doi:&#xa0;10.1002/cti2.1343</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1343</ArticleId><ArticleId IdType="pmc">PMC8423130</ArticleId><ArticleId IdType="pubmed">34512975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez F, Vazquez-Mu&#xf1;oz M, Canals A, Arce-&#xc1;lvarez A, Salazar-Ardiles C, Alvarez C, et al. . Intrahospital supervised exercise training improves survival rate among hypertensive patients with COVID-19. J Appl Physiol. (2023) 134:678&#x2013;84. doi:&#xa0;10.1152/japplphysiol.00544.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00544.2022</ArticleId><ArticleId IdType="pmc">PMC10010906</ArticleId><ArticleId IdType="pubmed">36727631</ArticleId></ArticleIdList></Reference><Reference><Citation>VasanthiDharmalingam P, Karuppagounder V, Watanabe K, Karmouty&#x2010;Quintana H, Palaniyandi SS, Guha A, et al. . SARS&#x2013;CoV-2 mediated hyperferritinemia and cardiac arrest: preliminary insights. Drug Discovery Today. (2021) 26:1265&#x2013;74. doi:&#xa0;10.1016/j.drudis.2021.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2021.01.014</ArticleId><ArticleId IdType="pmc">PMC7826001</ArticleId><ArticleId IdType="pubmed">33493677</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. (2020) 17:259&#x2013;60. doi:&#xa0;10.1038/s41569-020-0360-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. . Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. (2017) 7:9110. doi:&#xa0;10.1038/s41598-017-09536-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09536-z</ArticleId><ArticleId IdType="pmc">PMC5567209</ArticleId><ArticleId IdType="pubmed">28831119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. (2020) 5:802&#x2013;10. doi:&#xa0;10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054&#x2013;62. doi:&#xa0;10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811&#x2013;8. doi:&#xa0;10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. (2020) 41:3038&#x2013;44. doi:&#xa0;10.1093/eurheartj/ehaa623</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. (2020) 142:68&#x2013;78. doi:&#xa0;10.1161/CIRCULATIONAHA.120.047549</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. (2020) 16:297&#x2013;8. doi:&#xa0;10.1038/s41574-020-0353-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0353-9</ArticleId><ArticleId IdType="pmc">PMC7113912</ArticleId><ArticleId IdType="pubmed">32242089</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. (2021) 44:2645&#x2013;55. doi:&#xa0;10.2337/dc21-1318</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1318</ArticleId><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. (2021) 11:21. doi:&#xa0;10.1038/s41387-021-00163-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41387-021-00163-2</ArticleId><ArticleId IdType="pmc">PMC8223528</ArticleId><ArticleId IdType="pubmed">34168110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. (2020) 162:108142. doi:&#xa0;10.1016/j.diabres.2020.108142</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108142</ArticleId><ArticleId IdType="pmc">PMC7144611</ArticleId><ArticleId IdType="pubmed">32278764</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. doi:&#xa0;10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion J, Dudouet P, Kaphan E, Bregeon F, Dupont Tissot- H, et al. . 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. (2021) 48:2823&#x2013;33. doi:&#xa0;10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuyts WA, Agostini C, Antoniou KM, Bouros D, Chambers RC, Cottin V, et al. . The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. (2013) 41:1207&#x2013;18. doi:&#xa0;10.1183/09031936.00073012</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00073012</ArticleId><ArticleId IdType="pubmed">23100500</ArticleId></ArticleIdList></Reference><Reference><Citation>She YX, Yu QY, Tang XX. Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discovery. (2021) 7:52. doi:&#xa0;10.1038/s41420-021-00437-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00437-9</ArticleId><ArticleId IdType="pmc">PMC7960958</ArticleId><ArticleId IdType="pubmed">33723241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathology: A J Pathological Soc Great Britain Ireland. (2008) 214:199&#x2013;210. doi:&#xa0;10.1002/path.2277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2277</ArticleId><ArticleId IdType="pmc">PMC2693329</ArticleId><ArticleId IdType="pubmed">18161745</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. . Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. (2020) 20:1135&#x2013;40. doi:&#xa0;10.1016/S1473-3099(20)30434-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30434-5</ArticleId><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. (2020) 368:m1091. doi:&#xa0;10.1136/bmj.m1091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. . Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. biorxiv. (2020). doi:&#xa0;10.1101/2020.02.03.931766</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.03.931766</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. (2020) 285:198018. doi:&#xa0;10.1016/j.virusres.2020.198018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198018</ArticleId><ArticleId IdType="pmc">PMC7217790</ArticleId><ArticleId IdType="pubmed">32430279</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou W, Fu Y, Yue L, Chen G.-d, Cai X, Shuai M, et al. . Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. MedRxiv. (2020). doi:&#xa0;10.1101/2020.04.22.20076091</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.22.20076091</ArticleId></ArticleIdList></Reference><Reference><Citation>He L-H, Ren L.-F, Li J.-F, Wu Y.-N, Li X, Zhang L, et al. . Intestinal flora as a potential strategy to fight SARS-CoV-2 infection. Front Microbiol. (2020) 11:1388. doi:&#xa0;10.3389/fmicb.2020.01388</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01388</ArticleId><ArticleId IdType="pmc">PMC7295895</ArticleId><ArticleId IdType="pubmed">32582138</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasa S, Desai M, Chandrasekar VT, Patel HK, Kennedy KF, Roesch T, et al. . Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: A systematic review and meta-analysis. JAMA Netw Open. (2020) 3:e2011335. doi:&#xa0;10.1001/jamanetworkopen.2020.11335</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.11335</ArticleId><ArticleId IdType="pmc">PMC7290409</ArticleId><ArticleId IdType="pubmed">32525549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JK, Chang AY, Zaman A, Martin P, Rodriguez Fernandez- CM, Korkmaz M, et al. . Clinical outcome event adjudication in a 10-year prospective study of nucleos(t)ide analogue therapy for chronic hepatitis B. J Clin Transl Hepatol. (2020) 8:377&#x2013;84. doi:&#xa0;10.14218/JCTH.2020.00039</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2020.00039</ArticleId><ArticleId IdType="pmc">PMC7782110</ArticleId><ArticleId IdType="pubmed">33447520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Liu Q, Zhang F, Lui GC-Y, Tso EY, Yeoh YK, et al. . Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. (2021) 70:276&#x2013;84. doi:&#xa0;10.1136/gutjnl-2020-322294</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica chimica Acta. (2020) 506:145&#x2013;8. doi:&#xa0;10.1016/j.cca.2020.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.03.022</ArticleId><ArticleId IdType="pmc">PMC7102663</ArticleId><ArticleId IdType="pubmed">32178975</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematology. (2020) 7:e438&#x2013;40. doi:&#xa0;10.1016/S2352-3026(20)30145-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, et al. . Platelet gene expression and function in patients with COVID-19. Blood. (2020) 136:1317&#x2013;29. doi:&#xa0;10.1182/blood.2020007214</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb haemostasis. (2020) 18:1094&#x2013;9. doi:&#xa0;10.1111/jth.14817</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. (2017) 149:38&#x2013;44. doi:&#xa0;10.1016/j.thromres.2016.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, et al. . COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood J Am Soc Hematol. (2020) 136:489&#x2013;500. doi:&#xa0;10.1182/blood.2020006520</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. (2020) 77:683&#x2013;90. doi:&#xa0;10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. . Neurological associations of COVID-19. Lancet Neurol. (2020) 19:767&#x2013;83. doi:&#xa0;10.1016/S1474-4422(20)30221-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. . Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. (2020) 7:2221&#x2013;30. doi:&#xa0;10.1002/acn3.51210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. . The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. (2020) 143:3104&#x2013;20. doi:&#xa0;10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Samranvedhya J, et al. . Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. (2021) 373:n1098. doi:&#xa0;10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu Rev Med. (2023) 74:55&#x2013;64. doi:&#xa0;10.1146/annurev-med-043021-030635</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-030635</ArticleId><ArticleId IdType="pubmed">35914765</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, et al. . Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19. medRxiv. (2022). doi:&#xa0;10.1101/2022.09.25.22280335</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.25.22280335</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. (2020) 370:m3026. doi:&#xa0;10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2023) 401:2025. doi:&#xa0;10.1016/S0140-6736(23)01175-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01175-3</ArticleId><ArticleId IdType="pmc">PMC10256260</ArticleId><ArticleId IdType="pubmed">37307841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang Y.-m, Song W.-b, Li Q.-q, Xie H, Xu Q.-f, et al. . Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. (2020) 25:100463. doi:&#xa0;10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020) 87:18&#x2013;22. doi:&#xa0;10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. . Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. (2020) 383:590&#x2013;2. doi:&#xa0;10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post&#x2013;coronavirus disease. Heart Failure. (2021) 9:927&#x2013;37. doi:&#xa0;10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:5104. doi:&#xa0;10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Shaik R, Schneider L, Muppidi S, Tsui CT, et al. . Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults. Front Neurol. (2022) 13:1012668. doi:&#xa0;10.3389/fneur.2022.1012668</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, et al. . Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. MedRxiv. (2022). doi:&#xa0;10.1101/2022.08.08.22278543</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.08.22278543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med. (2005) 55:20&#x2013;31. doi:&#xa0;10.1093/occmed/kqi013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubb BP. Postural tachycardia syndrome. Circulation. (2008) 117:2814&#x2013;7. doi:&#xa0;10.1161/CIRCULATIONAHA.107.761643</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.761643</ArticleId><ArticleId IdType="pubmed">18506020</ArticleId></ArticleIdList></Reference><Reference><Citation>Karas B, Grubb BP, Boehm K, Kip K. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiology. (2000) 23:344&#x2013;51. doi:&#xa0;10.1111/j.1540-8159.2000.tb06760.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2000.tb06760.x</ArticleId><ArticleId IdType="pubmed">10750135</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR. Postural tachycardia syndrome (POTS). Circulation. (2013) 127:2336&#x2013;42. doi:&#xa0;10.1161/CIRCULATIONAHA.112.144501</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.144501</ArticleId><ArticleId IdType="pmc">PMC3756553</ArticleId><ArticleId IdType="pubmed">23753844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol. (2019) 73:1207&#x2013;28. doi:&#xa0;10.1016/j.jacc.2018.11.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.11.059</ArticleId><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. (2021) 22:803&#x2013;15. doi:&#xa0;10.1007/s11154-020-09615-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-020-09615-z</ArticleId><ArticleId IdType="pmc">PMC7688298</ArticleId><ArticleId IdType="pubmed">33241508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. (2020) 183:381&#x2013;7. doi:&#xa0;10.1530/EJE-20-0335</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. (2009) 6:5. doi:&#xa0;10.1186/1743-422X-6-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-5</ArticleId><ArticleId IdType="pmc">PMC2654877</ArticleId><ArticleId IdType="pubmed">19138419</ArticleId></ArticleIdList></Reference><Reference><Citation>Aemaz Ur Rehman M, Farooq H, Ali MM, Ebaad Ur Rehman M, Dar QA, Hussain A. The association of subacute thyroiditis with COVID-19: a systematic review. SN Compr Clin Med. (2021) 3:1515&#x2013;27. doi:&#xa0;10.1007/s42399-021-00912-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00912-5</ArticleId><ArticleId IdType="pmc">PMC8082479</ArticleId><ArticleId IdType="pubmed">33942028</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri A, Charlap E, Kim A. Subacute thyroiditis from COVID-19 infection: A case report and review of literature. Eur Thyroid J. (2021) 9:324&#x2013;8. doi:&#xa0;10.1159/000511872</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000511872</ArticleId><ArticleId IdType="pmc">PMC7705942</ArticleId><ArticleId IdType="pubmed">33708634</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JD, Shen Q, Cintron SA, Hiebert JB. Post-COVID-19 syndrome. Nurs Res. (2022) 71:164&#x2013;74. doi:&#xa0;10.1097/NNR.0000000000000565</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000565</ArticleId><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouslama B, Pierret C, Khelfaoui F, Bellann&#xe9;-Chantelot C, Donadieu J, H&#xe9;ritier S. Post-COVID-19 severe neutropenia. Pediatr Blood Cancer. (2021) 68. doi:&#xa0;10.1002/pbc.28866</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.28866</ArticleId><ArticleId IdType="pmc">PMC7883096</ArticleId><ArticleId IdType="pubmed">33355971</ArticleId></ArticleIdList></Reference><Reference><Citation>Denison MR, Graham RL, Donaldson EF, Eckerle LD, Baric RS. Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol. (2011) 8:270&#x2013;9. doi:&#xa0;10.4161/rna.8.2.15013</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.8.2.15013</ArticleId><ArticleId IdType="pmc">PMC3127101</ArticleId><ArticleId IdType="pubmed">21593585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta RK. Will SARS-CoV-2 variants of concern affect the promise of vaccines? Nat Rev Immunol. (2021) 21:340&#x2013;1. doi:&#xa0;10.1038/s41577-021-00556-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00556-5</ArticleId><ArticleId IdType="pmc">PMC8082481</ArticleId><ArticleId IdType="pubmed">33927376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillen HS, Kokic G, Farnung L, Dienemann C, Tegunov D, Cramer P. Structure of replicating SARS-CoV-2 polymerase. Nature. (2020) 584:154&#x2013;6. doi:&#xa0;10.1038/s41586-020-2368-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2368-8</ArticleId><ArticleId IdType="pubmed">32438371</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. (2021) 21:626&#x2013;36. doi:&#xa0;10.1038/s41577-021-00592-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00592-1</ArticleId><ArticleId IdType="pmc">PMC8351583</ArticleId><ArticleId IdType="pubmed">34373623</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez CE, Perdiguero B, Esteban M. Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines (Basel). (2021) 9. doi:&#xa0;10.3390/vaccines9030243</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030243</ArticleId><ArticleId IdType="pmc">PMC7999234</ArticleId><ArticleId IdType="pubmed">33799505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Parashar R, Kumar S, Faiq MA, Kumari C, Kulandhasamy M, et al. . Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. J Med Virol. (2022) 94:1300&#x2013;14. doi:&#xa0;10.1002/jmv.27467</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27467</ArticleId><ArticleId IdType="pmc">PMC9011477</ArticleId><ArticleId IdType="pubmed">34811761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao K, Tzou PL, Nouhin J, Gupta RK, Oliveira T, Kosakovsky Pond SL, et al. . The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. (2021) 22:757&#x2013;73. doi:&#xa0;10.1038/s41576-021-00408-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00408-x</ArticleId><ArticleId IdType="pmc">PMC8447121</ArticleId><ArticleId IdType="pubmed">34535792</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, Bouhaddou M, Reuschl A-K, Zuliani-Alvarez L, Polacco B, Pelin A, et al. . Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature. (2022) 602:487&#x2013;95. doi:&#xa0;10.1038/s41586-021-04352-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04352-y</ArticleId><ArticleId IdType="pmc">PMC8850198</ArticleId><ArticleId IdType="pubmed">34942634</ArticleId></ArticleIdList></Reference><Reference><Citation>Leary S, Gaudieri S, Parker MD, Chopra A, James I, Pakala S, et al. . Generation of a novel SARS-CoV-2 sub-genomic RNA due to the R203K/G204R variant in nucleocapsid: homologous recombination has potential to change SARS-CoV-2 at both protein and RNA level. Pathog Immun. (2021) 6:27. doi:&#xa0;10.20411/pai.v6i2.460</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v6i2.460</ArticleId><ArticleId IdType="pmc">PMC8439434</ArticleId><ArticleId IdType="pubmed">34541432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourier T, Shuaib M, Hala S, Mfarrej S, Alofi F, Naeem R, et al. . Saudi Arabian SARS-CoV-2 genomes implicate a mutant Nucleocapsid protein in modulating host interactions and increased viral load in COVID-19 patients. medRxiv. (2021). doi:&#xa0;10.1101/2021.05.06.21256706</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.06.21256706</ArticleId></ArticleIdList></Reference><Reference><Citation>Boarman A. Omicron is the dominant COVID variant for two reasons. (2021).</Citation></Reference><Reference><Citation>Boppana S, Qin K, Files JK, Russell RM, Stoltz R, Bibollet- Ruche F, et al. . SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence. PloS Pathog. (2021) 17:e1009761. doi:&#xa0;10.1371/journal.ppat.1009761</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009761</ArticleId><ArticleId IdType="pmc">PMC8318272</ArticleId><ArticleId IdType="pubmed">34270631</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626&#x2013;38. doi:&#xa0;10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, et al. . The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med. (2021) 9:622&#x2013;42. doi:&#xa0;10.1016/S2213-2600(21)00218-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00218-6</ArticleId><ArticleId IdType="pmc">PMC8102044</ArticleId><ArticleId IdType="pubmed">33965003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramontana F, Battisti S, Napoli N, Strollo R. Immuno-endocrinology of COVID-19: the key role of sex hormones. Front Endocrinol (Lausanne). (2021) 12:726696. doi:&#xa0;10.3389/fendo.2021.726696</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.726696</ArticleId><ArticleId IdType="pmc">PMC8675353</ArticleId><ArticleId IdType="pubmed">34925228</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadi N, Wu SC, Spihlman AP, Moulton VR. What&#x2019;s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol. (2020) 11:562631. doi:&#xa0;10.3389/fimmu.2020.02147</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02147</ArticleId><ArticleId IdType="pmc">PMC7485092</ArticleId><ArticleId IdType="pubmed">32983176</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold CG, Libby A, Vest A, Hopkinson A, Monte AA. Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes. Biol Sex Differ. (2022) 13:7. doi:&#xa0;10.1186/s13293-022-00417-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-022-00417-3</ArticleId><ArticleId IdType="pmc">PMC8894555</ArticleId><ArticleId IdType="pubmed">35246245</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiering AE, de Vries TJ. Why females do better: the X chromosomal TLR7 gene-dose effect in COVID-19. Front Immunol. (2021) 12:756262. doi:&#xa0;10.3389/fimmu.2021.756262</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.756262</ArticleId><ArticleId IdType="pmc">PMC8632002</ArticleId><ArticleId IdType="pubmed">34858409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MS, Moulin TC, Schi&#xf6;th HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. (2021) 71:3&#x2013;8. doi:&#xa0;10.1007/s12020-020-02536-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02536-6</ArticleId><ArticleId IdType="pmc">PMC7657570</ArticleId><ArticleId IdType="pubmed">33179220</ArticleId></ArticleIdList></Reference><Reference><Citation>Beacon TH, Delcuve GP, Davie JR. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus(1). Genome. (2021) 64:386&#x2013;99. doi:&#xa0;10.1139/gen-2020-0124</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/gen-2020-0124</ArticleId><ArticleId IdType="pubmed">33086021</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengsiwaritt W, Jittikoon J, Chaikledkaew U, Udomsinprasert W. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis. Rev Med Virol. (2022) 32:e2323. doi:&#xa0;10.1002/rmv.2323</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2323</ArticleId><ArticleId IdType="pubmed">34997794</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva JS, Montagnoli TL, Rocha BS, Tacco ML, Marinho SC, Zapata-Sudo G. Estrogen receptors: therapeutic perspectives for the treatment of cardiac dysfunction after myocardial infarction. Int J Mol Sci. (2021) 22. doi:&#xa0;10.3390/ijms22020525</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020525</ArticleId><ArticleId IdType="pmc">PMC7825655</ArticleId><ArticleId IdType="pubmed">33430254</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. . Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. (2020) 21:e13128. doi:&#xa0;10.1111/obr.13128</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13128</ArticleId><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Reidy L, Romero M, Diaz A, Cray C, Kahl K, et al. . The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing. Int J Obes (Lond). (2022) 46:427&#x2013;32. doi:&#xa0;10.1038/s41366-021-01016-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-01016-9</ArticleId><ArticleId IdType="pmc">PMC8572364</ArticleId><ArticleId IdType="pubmed">34744161</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. In: Mayo Clinic Proceedings. Elsevier; (2020) 95(7):1445&#x2013;53. doi:&#xa0;10.1016/j.mayocp.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7236707</ArticleId><ArticleId IdType="pubmed">32622449</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Reidy L, Cray C, Diaz A, Romero M, Kahl K, et al. . Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PloS One. (2021) 16:e0245424. doi:&#xa0;10.1371/journal.pone.0245424</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245424</ArticleId><ArticleId IdType="pmc">PMC7990309</ArticleId><ArticleId IdType="pubmed">33760825</ArticleId></ArticleIdList></Reference><Reference><Citation>Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. (2021) 33:479&#x2013;98. doi:&#xa0;10.1016/j.cmet.2021.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC7825982</ArticleId><ArticleId IdType="pubmed">33529600</ArticleId></ArticleIdList></Reference><Reference><Citation>Krams IA, Luoto S, Rantala MJ, J&#xf5;ers P, Krama T. Covid-19: fat, obesity, inflammation, ethnicity, and sex differences. Pathogens. (2020) 9. doi:&#xa0;10.3390/pathogens9110887</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9110887</ArticleId><ArticleId IdType="pmc">PMC7692736</ArticleId><ArticleId IdType="pubmed">33114495</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliese G, Liccardi A, Graziadio C, Barrea L, Muscogiuri G, Colao A. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int J Obes (Lond). (2022) 46:449&#x2013;65. doi:&#xa0;10.1038/s41366-021-01035-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-01035-6</ArticleId><ArticleId IdType="pubmed">35058571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem. (2022) 477:1155&#x2013;93. doi:&#xa0;10.1007/s11010-022-04356-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-022-04356-w</ArticleId><ArticleId IdType="pmc">PMC8793096</ArticleId><ArticleId IdType="pubmed">35084674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis childhood. (2021) 106:429&#x2013;39. doi:&#xa0;10.1136/archdischild-2020-320338</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320338</ArticleId><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z, et al. . Association of age with SARS-CoV-2 antibody response. JAMA network Open. (2021) 4:e214302&#x2013;e214302. doi:&#xa0;10.1001/jamanetworkopen.2021.4302</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.4302</ArticleId><ArticleId IdType="pmc">PMC7985726</ArticleId><ArticleId IdType="pubmed">33749770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Curtis N. Why does the severity of COVID-19 differ with age?: understanding the mechanisms underlying the age gradient in outcome following SARS-CoV-2 infection. Pediatr Infect Dis J. (2022) 41:e36&#x2013;45. doi:&#xa0;10.1097/INF.0000000000003413</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003413</ArticleId><ArticleId IdType="pmc">PMC8740029</ArticleId><ArticleId IdType="pubmed">34966142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartleson JM, Radenkovic D, Covarrubias AJ, Furman D, Winer DA, Verdin E. SARS-CoV-2, COVID-19 and the ageing immune system. Nat Aging. (2021) 1:769&#x2013;82. doi:&#xa0;10.1038/s43587-021-00114-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-021-00114-7</ArticleId><ArticleId IdType="pmc">PMC8570568</ArticleId><ArticleId IdType="pubmed">34746804</ArticleId></ArticleIdList></Reference><Reference><Citation>Vono M, Huttner A, Lemeille S, Martinez-Murillo P, Meyer B, Baggio S, et al. . Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Rep. (2021) 37. doi:&#xa0;10.1016/j.celrep.2021.109773</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109773</ArticleId><ArticleId IdType="pmc">PMC8440231</ArticleId><ArticleId IdType="pubmed">34587479</ArticleId></ArticleIdList></Reference><Reference><Citation>Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. (2012) 16:S27&#x2013;36. doi:&#xa0;10.4103/2230-8210.94253</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.94253</ArticleId><ArticleId IdType="pmc">PMC3354930</ArticleId><ArticleId IdType="pubmed">22701840</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazucanti CH, Egan JM. SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? Immun Ageing. (2020) 17:21. doi:&#xa0;10.1186/s12979-020-00192-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00192-y</ArticleId><ArticleId IdType="pmc">PMC7325192</ArticleId><ArticleId IdType="pubmed">32612666</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi L, Malek M, Ismail-Beigi F, Khamseh ME. Challenging issues in the management of cardiovascular risk factors in diabetes during the COVID-19 pandemic: A review of current literature. Adv Ther. (2020) 37:3450&#x2013;62. doi:&#xa0;10.1007/s12325-020-01417-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01417-8</ArticleId><ArticleId IdType="pmc">PMC7338141</ArticleId><ArticleId IdType="pubmed">32632851</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman-Edelstein M, Guetta T, Barnea A, Waldman M, Ben- Dor N, Barac YD, et al. . Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Cardiovasc Diabetol. (2021) 20:90. doi:&#xa0;10.1186/s12933-021-01275-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01275-w</ArticleId><ArticleId IdType="pmc">PMC8078096</ArticleId><ArticleId IdType="pubmed">33906662</ArticleId></ArticleIdList></Reference><Reference><Citation>Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B, et al. . Impaired leucocyte functions in diabetic patients. Diabetes Med. (1997) 14:29&#x2013;34. doi:&#xa0;10.1002/(ISSN)1096-9136</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(ISSN)1096-9136</ArticleId><ArticleId IdType="pubmed">9017350</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers KL, Marleau AM, Mahon JL, McManus R, Hramiak I, Singh B. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol. (2006) 121:81&#x2013;9. doi:&#xa0;10.1016/j.clim.2006.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2006.05.015</ArticleId><ArticleId IdType="pubmed">16859998</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. (2020) 16:442&#x2013;9. doi:&#xa0;10.2174/18756417MTAxgODQqy</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/18756417MTAxgODQqy</ArticleId><ArticleId IdType="pmc">PMC7475801</ArticleId><ArticleId IdType="pubmed">31657690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. (2015) 144:171&#x2013;85. doi:&#xa0;10.1111/imm.12394</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12394</ArticleId><ArticleId IdType="pmc">PMC4298412</ArticleId><ArticleId IdType="pubmed">25262977</ArticleId></ArticleIdList></Reference><Reference><Citation>Meshkani R, Vakili S. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clin Chim Acta. (2016) 462:77&#x2013;89. doi:&#xa0;10.1016/j.cca.2016.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2016.08.015</ArticleId><ArticleId IdType="pubmed">27570063</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuschik L, Riabov V, Schmuttermaier C, Sevastyanova T, Weiss C, Kl&#xfc;ter H, et al. . Hyperglycemia induces inflammatory response of human macrophages to CD163-mediated scavenging of hemoglobin-haptoglobin complexes. Int J Mol Sci. (2022) 23. doi:&#xa0;10.3390/ijms23031385</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031385</ArticleId><ArticleId IdType="pmc">PMC8836198</ArticleId><ArticleId IdType="pubmed">35163309</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrepo BI, Twahirwa M, Jagannath C. Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients. Hum Immunol. (2021) 82:124&#x2013;9. doi:&#xa0;10.1016/j.humimm.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC9381160</ArticleId><ArticleId IdType="pubmed">33303215</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilias I, Jahaj E, Kokkoris S, Zervakis D, Temperikidis P, Magira E, et al. . Clinical study of hyperglycemia and SARS-CoV-2 infection in intensive care unit patients. In Vivo. (2020) 34:3029&#x2013;32. doi:&#xa0;10.21873/invivo.12136</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12136</ArticleId><ArticleId IdType="pmc">PMC7652529</ArticleId><ArticleId IdType="pubmed">32871848</ArticleId></ArticleIdList></Reference><Reference><Citation>Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol. (2013) 9:255&#x2013;65. doi:&#xa0;10.1038/nrneph.2013.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.44</ArticleId><ArticleId IdType="pubmed">23507826</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa Triana JF, M&#xe1;rquez Salas DA, Cabrera Silva JS, Alvarado Castro CC, Buitrago Sandoval AF. COVID-19 y enfermedad cardiovascular. Rev Colombiana Cardiolog&#xed;a. (2020) 27:166&#x2013;74. doi:&#xa0;10.1016/j.rccar.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rccar.2020.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Tejeda JJ, Hern&#xe1;ndez-P&#xe9;rez C, Aguilera-Vel&#xe1;zquez Y. Afectaci&#xf3;n del sistema cardiovascular en la infecci&#xf3;n por SARS-CoV-2. Universidad M&#xe9;dica Pinare&#xf1;a. (2020) 16:1&#x2013;11.</Citation></Reference><Reference><Citation>Goudouris ES, Pinto-Mariz F, Mendonca LO, Aranda CS, Guimaraes RR, Kokron C, et al. . Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study. J Clin Immunol. (2021) 41:1479&#x2013;89. doi:&#xa0;10.1007/s10875-021-01066-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01066-8</ArticleId><ArticleId IdType="pmc">PMC8221557</ArticleId><ArticleId IdType="pubmed">34164762</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith NP, Goncalves B, Charbit L, Grzelak M, Beretta C, Planchais T. et al.. Distinct systemic and mucosal immune responses during acute SARS-coV-2 infection. Nat Immunol. (2021) 22(11):1428&#x2013;39. doi:&#xa0;10.1038/s41590-021-01028-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01028-7</ArticleId><ArticleId IdType="pmc">PMC8553615</ArticleId><ArticleId IdType="pubmed">34471264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>